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Abstract 
Chronic fatigue syndrome (CFS), Myalgic Encephalomyelitis (ME) and 
Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS) refer to a 
debilitating illness without a universally accepted or well-understood etiology. 
Some experts have suggested that there are multiple pathways to the development 
of ME and CFS, which may also indicate multiple onset patterns. Due to 
unanswered questions regarding etiology, the onset of ME and CFS is considered 
a key area of inquiry. 
Case criteria for ME and CFS and much of the academic literature suggest 
that patients typically experience one of two possible onset patterns: sudden or 
gradual. Many experts consider the mode of ME and CFS onset an important 
factor for differentiating patients on key dimensions including etiology, health 
status, prognosis, and psychiatric comorbidity. Previous literature has suggested a 
link between sudden ME and CFS onset and a viral/infectious etiology, lower 
psychopathology, and worse health outcomes. However, other studies have found 
opposite or inconclusive findings. In order to replicate and build on previous 
research, the current study is an investigation of whether mode of onset 
differentiates individuals with ME and CFS on etiology, psychopathology, and 
daily functioning. It was hypothesized that individuals with sudden onsets would 
more likely report that a virus/infection preceded their illness, attribute their 
illness to physical causes, evidence lower lifetime psychiatric comorbidity, report 
poorer physical functioning, and have better mental health outcomes compared to 
the gradual onset group. Hypotheses were tested using multivariate analyses of 
 2	  
variance (MANOVA) and the Pearson’s chi-squared test of independence. Results 
revealed that mode of illness onsetdid not differentiate individuals on key factors 
related to etiology, psychopathology, and prognosis.  
 The lack of a universal definition for mode of illness onset is likely 
contributing to the inconsistencies in the percentage of sudden versus gradual ME 
and CFS onsets reported in the literature. Given the ambiguous etiology, complex 
symptom profile, and heterogeneous onset patterns associated with ME and CFS, 
it would be useful to better define onset. An in-depth investigation of ME and 
CFS onset can provide insight into early symptoms, onset duration, and the 
progression of functional disability. Few studies have utilized qualitative inquiry 
to understand the patient’s perspective of onset. Based on previous research 
documenting the rich information that can be gained from personal illness 
narratives, the second phase of the study involved phone interviews with 
individuals with ME and CFS. A qualitative descriptive approach was used to 
gain rich descriptions of illness onset from the patients’ point of view. Overall, 
qualitative findings revealed detailed descriptions of ME and CFS onset 
experiences. Major themes that emerged from the data included: onset/illness 
progression patterns, illness causes, methods of adapting and coping, hardworking 
and active lives prior to onset, healthy lives prior to onset, prior health problems, 
comorbid health conditions, emotional responses to onset, exertional effects, the 
illness as life limiting, stress, traumatic experiences, lack of support, support, and 
treatment limitations. A closer examination of the onset/illness progression 
patterns that emerged from the data provided evidence that individuals with ME 
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and CFS experience complex onset patterns. Furthermore, the study findings 
suggest that the method of categorizing individuals into sudden versus gradual 
onset groups may not be useful as it fails to capture the more nuanced and varied 
onset experiences. Prospective research studies that capture the onset period as it 
is developing could lead to improvements in the way we define and assess ME 
and CFS onset, and may also lead to methods for early detection, prevention, and 
individualized treatment approaches for this multifaceted and debilitating illness.
 4	  
Onset Patterns of Chronic Fatigue Syndrome and Myalgic Encephalomyelitis:  
A Mixed Method Approach 
Chronic fatigue syndrome (CFS) is a highly complex illness that results in 
significant disability (Tiersky et al., 2001) and a considerably diminished quality 
of life (Anderson, Ferrans, & Estwing, 1997).  The most widely used case criteria 
for CFS was developed by Fukuda et al. (1994) and it defines CFS as the 
experience of six months of severe fatigue in concurrence with at least four out of 
eight specified symptoms (e.g. memory and concentration impairment, sore 
throats, tender lymph nodes, muscle pain, joint pain, headaches, unrefreshing 
sleep, and post-exertional malaise). The Fukuda et al. (1994) criteria also stipulate 
that individuals affected with CFS are severely impacted in their ability to 
function in many areas of their lives. CFS is also associated with and frequently 
referred to as Myalgic Encephalomyelitis (ME; Carruthers et al., 2011), Myalgic 
Encephalomyelitis/chronic fatigue syndrome (ME/CFS; Carruthers et al., 2003), 
and myalgic encephalopathy (Shepherd & Chaudhuri, 2001). In addition to the 
Fukuda et al. (1994) case definition of CFS, three major case definitions in the 
field are the Carruthers et al. (2003) clinical case criteria for ME/CFS, the 
Carruthers et al. (2011) International Consensus Criteria for ME, and the most 
recent Institute of Medicine (IOM) Diagnostic Criteria for Systemic Exertion 
Intolerance Disease (SEID; Institute of Medicine, 2015). Unlike the Fukuda et al. 
(1994) criteria, Carruthers et al. (2003; 2011) and the IOM (2015) require the 
presence of cardinal symptoms for the illness, such as post-exertional malaise. 
The etiology of ME and CFS is not well understood, and a specific cause has not 
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yet been established. There are different proposed theories regarding the factors 
that might precipitate onset, including theories relating to possible viral or 
infectious triggers, environmental triggers, stressful events, or a combination of 
these factors (Komaroff, 1988, 1994; Salit, 1997). It has been suggested by some 
that there may be different pathways leading to the development of symptoms 
associated with CFS (Jason, Corradi, Torres-Harding, Taylor, & King, 2005; 
Salit, 1997). Due to continued questions regarding etiology, the period of onset 
for the illness is of considerable interest to researchers in the field. Much of the 
literature on ME and CFS related to onset suggests that individuals experience 
either a sudden/acute onset in which symptoms appear over a short period of time 
(e.g. a few hours, days, or weeks) or a slower, gradual onset in which symptoms 
may develop over a period of months or even years (Komaroff, 1998). There is 
not yet a universal definition for assessing mode of illness onset (sudden versus 
gradual), and this is reflected in the varying language used across ME and CFS 
studies and case definitions.  
Illness Onset-HIV and MS 
The onset of clinical symptoms is considered an important phase of illness 
development for many chronic illnesses, including those with a known cause, 
such as acute human immunodeficiency virus (HIV), and illnesses without a clear 
identifiable cause, such as Multiple Sclerosis (MS). In an effort to better 
understand how illness onset periods are characterized, it can be beneficial to 
study a chronic illness such as HIV, which has a well-defined viral and 
immunological etiology. While previous research has linked ME and CFS to a 
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viral etiology (Ablashi et al., 2000; Beqaj, Lerner, & Fitzgerald, 2008; Chapenko 
et al., 2006; Chia, 2005; Holmes et al., 1987; Levine, 2001) as well as to immune 
dysfunction (Broderick et al., 2010), there is not a universally agreed upon cause 
for ME and CFS. Therefore, it is also beneficial to study the onset patterns of 
other chronic illnesses of unknown origin, such as MS. The identification of 
initial clinical features and symptoms, as well as the chronological timeline 
associated with onset is important, as it can contribute to the development of 
effective methods for early detection, diagnosis, and treatment.   
 Acute human immunodeficiengradcy virus (HIV) infection is a disease 
with a well documented progression. The initial onset phase occurs after a person 
is exposed to HIV. As many as 50 to 90 % of individuals who contract HIV 
develop symptoms (e.g. fever, fatigue, myalgias/arthralgias, rash, and headaches) 
within one to four weeks after transmission, which can persist for approximately 
two to four weeks. At this early phase it can be difficult to diagnose HIV infection 
since it is characterized by symptoms that are also associated with other illnesses 
including Epstein-Barr virus and influenza. Tests that are available to detect HIV 
following infection include the HIV RNA viral load (detected within 11 to 12 
days of infection), the p24 antigen (detected 14 to 15 days from infection) and 
HIV enzyme-linked immunosorbent assay (detected within three to eight weeks 
from infection; Chu & Selwyn, 2010). 
Multiple Sclerosis (MS) is a chronic neurodegenerative disorder that 
causes lesions in the central nervous system (CNS) and disintegration of the 
myelin sheaths of neurons. A specific cause of MS has not been identified to date; 
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however, it has been theorized that environmental factors (e.g. infection) in 
conjunction with genetic risk factors can lead to the development of MS 
(Compston & Coles, 2008). MS is now considered an organic neurodegenerative 
disease; however, there was a time when the medical community considered it to 
be psychogenic in nature and people were often misdiagnosed with the labels 
hysterical personality disorder or conversion disorder (Feinstein, 2007). 
Additionally, early theories about the etiology of MS suggested that it was 
brought on by emotional stress from an oedipal complex or an ‘MS-prone 
personality’ (Murray, 1995). Richman and Jason (2001) identified parallels 
between MS and CFS including the disproportionate number of women affected 
in both illness populations, as well as the tendency for physicians to associate 
CFS with psychogenic factors, as these attributions are similar to the early 
psychogenic theories made by physicians regarding the etiology of MS.  
The onset and course of MS is complex. The McDonald criteria and later 
revisions to this criteria outline different scenarios of illness progression that 
indicate the presence of MS (McDonald et al., 2001; Polman et al., 2011; Polman 
et al., 2005). Four of the five scenarios indicate that individuals with MS 
experience what is referred to as an “attack” or “acute inflammatory 
demyelinating event in the CNS with a duration of at least 24 hours in the absence 
of fever or infection” (p. 293).  Some scenarios involve only one attack prior to 
the progression of the illness, whereas other scenarios involve two or more attacks 
prior to illness progression. A fifth scenario does not require the experience of an 
attack and involves the insidious/gradual progression of symptoms over the 
 8	  
course of a year.  It has also been reported that inflammation of the CNS may 
occur many years prior to the development of clinical symptoms, further 
complicating the identification of a clear illness onset (Compston & Coles, 2008). 
The McDonald criteria (2001) suggest that the onset and progression of MS is 
varied, providing evidence for subtypes of the illness.  
 In general, there are challenges to identifying specific onset patterns 
associated with chronic illnesses. For instance, some illness onsets are 
characterized by non-specific symptoms that overlap with other chronic health 
conditions. Additionally, people may experience initial symptoms of an illness 
without realizing that something is wrong. The identification of initial symptoms 
and signs may be especially difficult for illnesses of unknown etiology such as 
MS, as well as ME and CFS. In the case of ME and CFS, there may be multiple 
pathways to the illness, as has been suggested by researchers in the field (Jason et 
al., 2005; Salit, 1997), which may also involve different patterns of illness 
progression.  
Illness Onset in Case Definitions of ME, CFS, ME/CFS, and SEID 
There is controversy as to whether the illness labels CFS (Fukuda et al., 
1994), ME (Carruthers et al., 2011), ME/CFS (Carruthers et al., 2003), myalgic 
encephalopathy (Shepherd & Chaudhuri, 2001), and SEID (Institute of Medicine, 
2015) represent one distinct condition, whether they are part of an illness 
spectrum, or whether they are simply different terms used to describe the same 
condition. CFS, ME, ME/CFS, and the recently named SEID, are often associated 
with different case criteria. Each case definition provides a description of onset, 
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and while there are similarities across these descriptions, there are some key 
differences regarding how onset duration is defined across these various 
definitions.   
Early case criteria developed by Holmes et al. (1988) specify that the 
illness must have a “new onset of persistent or relapsing, debilitating fatigue” 
without any previous history of similar problems (p. 388).  Additionally, Holmes 
et al. (1988) stipulate that the main symptoms of CFS must occur over a few 
hours or days, indicating a sudden or acute onset. According to Holmes et al. 
(1988), symptoms are only met if they begin at the time of the fatigue onset or 
following onset. Another case criteria for CFS is referred to as the Oxford Criteria 
(Sharpe et al., 1991) which stipulate that CFS involves a “definite” onset as well 
as clear evidence of infection at the time of onset or first symptoms. Similar to the 
Oxford Criteria (Sharpe et al., 1991) the Fukuda et al. (1994) criteria describe the 
onset of the fatiguing illness as “new” and “definite” (p. 956). The Institute of 
Medicine (IOM) recently developed a new case definition and renamed the illness 
as Systemic Exertion Intolerance Disease (SEID; Institute of Medicine, 2015). 
Similar to the Oxford Criteria (Sharpe et al., 1991) and Fukuda et al. (1994) 
criteria, the case criteria for SEID specifies that the fatiguing illness is of a “new 
or definite onset” and not “lifelong.”  These vague terms were included in the 
case criteria in order to exclude individuals who have experienced lifelong 
fatigue. Reeves et al. (2003) later clarified that the purpose for the requirement of 
“new and definite onset” fatigue was to exclude those individuals with a primary 
personality or somatization disorder, which are both characterized as lifelong with 
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unexplained somatic symptoms. Additionally, Reeves et al. (2003) indicated that 
it is clinically difficult to identify whether fatigue is “new and definite.”   Levine 
(1997) reported that the requirement for an “acute onset” of CFS was left out of 
the Fukuda et al., (1994), as Fukuda did not find that the presence of infection 
differentiated individuals with CFS from those without the illness (Levine, 1997). 
The terms Myalgic Encephalomyelitis  (ME) and Myalgic 
Encephalomyelitis/chronic fatigue syndrome (ME/CFS) have corresponding case 
criteria (see Carruthers et al., 2003; Carruthers et al., 2011), which are different 
from the Fukuda et al. (1994) criteria in that they require what are considered by 
many to be key symptoms of the illness (e.g. post exertional malaise and 
cognitive dysfunction).  The Carruthers et al. (2003) criteria for ME/CFS specify 
that an individual must have a “significant degree of new onset” fatigue (p. 11). 
Similar to the Holmes et al. (1988) criteria for CFS, the case criteria for ME/CFS 
stipulate that symptoms can only be counted as meeting criteria if they occur or 
become significantly worse after the onset of the illness. Carruthers et al., (2003) 
describe onset as “distinct” and assert that most individuals experience an acute 
onset; however, they also assert that some individuals are unhealthy prior to their 
ME/CFS onset and may not be able to identify a specific trigger for the 
development of ME/CFS, or they may experience a more “gradual” or “insidious” 
onset (p. 12). Furthermore, Carruthers et al. (2003) suggest that many individuals 
who experience immune dysfunction experience it most profoundly in the “acute 
onset stage” and that these symptoms of immune dysfunction fade or come and go 
as the illness becomes more chronic.  According to Carruthers et al. (2003) 
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individuals with a viral acute onset show more symptoms of immune dysfunction 
compared to those who report a more gradual onset.  
The Carruthers et al. (2003) criteria were created to serve as a guide for 
health clinician’s diagnosing the condition, and the authors suggest that when 
assessing for the presence of ME/CFS, health care providers should gather 
information regarding the date of illness onset, the presence of an identifiable 
trigger or “prodromal event” (p.22), the symptoms present at the time of onset, as 
well as symptom course and symptom duration. They also provide guidelines for 
distinguishing ME/CFS from other conditions such as depression and 
somatization disorders. Additionally, Carruthers et al. (2003) report that one 
common distinguisher between ME/CFS and depression is the sudden onset 
common in those with ME/CFS.  Furthermore, Carruthers et al. (2003) report that 
prior to illness onset, individuals with ME/CFS often are active and that the 
illness onset often follows “acute pro-upper respiratory infections, bronchitis, 
sinusitis, gastroenteritis, or an acute ‘flue-like’ illness” (p. 9).  Additionally, they 
discuss prodromal events such as immunization, anesthesia, and pollutant 
exposure as events that can cause stress on the neuroimmunoendocrine regulatory 
system.  Other possible triggers discussed include trauma or more rarely, a blood 
transfusion. Carruthers et al. (2003) assert that an affected person will then 
experience a “progressive decline in health and develop a cascade of symptoms,” 
which occurs “within days or weeks” of the triggering event (p. 9). They further 
suggest that those who experience gradual progression of the illness are less likely 
to report “discrete triggering events” (p. 9).  
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Similar to CFS and ME/CFS, past case definitions of ME have presented 
varying descriptions of onset. For instance, an early definition for ME by Ramsay 
(1988) asserts that the onset may be sudden without an identifiable cause, and 
may be accompanied by acute vertigo. Ramsay reports that there is often a history 
of infection of the upper respiratory track or sometimes in the gastrointestinal 
tract in patients with ME.  While Ramsey suggested that most individuals with 
ME experience an acute onset, he suggested that a subset of individuals 
experience an insidious onset (Dowsett, Ramsay, McCartney, & Bell, 1990).  
Hyde’s Nightingale Definition of ME (2007) stipulates that ME is both 
chronic and disabling and is characterized by an acute onset. Additionally, Hyde 
describes ME as an epidemic or an endemic occurring in two phases (Primary 
infectious Phase and Primary Chronic Phase). Additionally, Hyde (2007) 
indicates that ME often follows multiple, minor infections in individuals with 
susceptible immune systems or immune systems that are weakened by severe 
stressors (e.g. contact with infectious persons, exhaustion, trauma, immunizations, 
epidemic disease, travel and exposure to virulent agents). Hyde describes the 
initial phase of ME as the Primary Infection Phase, which is characterized as an 
epidemic or endemic infectious disease with an incubation period of between four 
and seven days.  He describes the second phase as the Secondary Chronic Phase, 
occurring with two to seven days of the Primary Infection Phase. In this phase, 
Hyde asserts that there are measurable changes in the central nervous system 
(CNS) of an affected individual and that this phase is the chronic form of the 
disease that is most commonly depictive of ME. Understanding the cause of ME 
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can be complicated, as Hyde asserts that all cases of epidemic and primary ME 
result from an infectious or autoimmune agent, but he also suggests that there are 
often other potential causes that may go unnoticed prior to the onset of illness or 
as part of the illness. The presence of other causal factors is also discussed in 
Goudsmit et al. (2009). With regard to epidemic and primary ME, Hyde suggests 
that there is a lack of consensus regarding whether there is a viral or infectious 
etiology of the illness. He suggests that this lack of consensus may be due to the 
indication that there are patients who experience an acute onset and those that 
experience a more gradual onset. Hyde suggests that an acute onset is always 
indicated in a Primary ME patient group whereas a gradual onset may be more 
indicative of the chronic fatigue syndrome label. Additionally, he expressed the 
belief that ME is caused by an enterovirus and that those individuals that he has 
tested for viral infection all experienced an acute onset. While it is not 
emphasized, Hyde discusses the potential for the development of ME as a result 
of non-infectious agents (termed Secondary ME), such as exposure to toxic 
chemicals, which he reported observing in his medical practice. He reports that 
like Primary ME groups, Secondary ME affects the CNS, and in contrast he 
suggests that Secondary ME can be more severe.  
The International Consensus Criteria for ME (ME-ICC; Carruthers et al., 
2011) also provide information regarding illness onset. Carruthers et al. (2011) 
assert that most patients have an acute infectious onset with flu-like and/or 
respiratory symptoms, but they also acknowledge that a gradual onset does occur 
in a subset of individuals. Additionally the ME-ICC criteria recommend that 
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patients are classified into subtypes based on whether their onset is 
acute/infectious or gradual, as well as their severity of onset, as this may predict 
the severity of the chronic course of the illness (2011). 
Defining Onset 
 As is revealed in the various case definitions for CFS, ME, and ME/CFS, 
the descriptions of illness onset may have some commonalities but also vary in 
the language and specifications used to differentiate sudden/acute onset and 
gradual/insidious onset. The lack of a universal definition for mode of illness 
onset may be contributing to the inconsistencies in the percentage of individuals 
experiencing sudden versus gradual onset reported in the literature. For instance, 
some have reported that as many as 91% of a tertiary care sample of individuals 
with CFS experienced an acute onset following infection (Peterson, Schenck, & 
Sherman, 1991); whereas other findings taken from community based samples of 
CFS have found that as many as 63% (Jason et al., 1999) to 77% (Nisenbaum et 
al., 2003) of individuals endorsed a more gradual or insidious onset of CFS (Jason 
et al., 1999; Nisenbaum et al., 2003).  
In his study of pediatric CFS, Bell (1995) found that approximately 45% of 
children and adolescents with CFS experienced an acute onset. There may be 
multiple reasons for the varying reports of onset duration across these studies, 
including the samples studied (community-based samples versus tertiary care 
samples). Levine et al. (1992) evaluated individuals who experienced CFS-related 
symptoms from four separate communities in different parts of the country that 
had experienced outbreaks of CFS between the years 1984 and 1986, and found 
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that in three of the communities, the majority of individuals experienced an acute 
onset, whereas in the fourth community, only 33% experienced acute onset.  
Other possible reasons for these discrepancies are the use of different case criteria 
used to select individuals with CFS and different definitions for mode of illness 
onset. Bell (1995) suggested that the definition used to define sudden and gradual 
onset may influence the number of participants placed in each group.    
There is not one universally used or empirically derived definition of onset 
duration for ME and CFS. Researchers interested in assessing mode of illness 
onset have used various definitions. Often, the distinction is made between 
sudden/acute onset and insidious/gradual onset, but the duration length prescribed 
to each category differs. For instance, DeLuca, Johnson, Ellis, and Natelson 
(1997) defined sudden onset for CFS as an unrecoverable “viral-like illness” that 
could be traced to a definite date. Gradual onset was described as a “slow 
progression of symptoms over a period of weeks to several months” or longer (p. 
85). Participants were classified under these onset definitions based on 
independent assessments from a physician and a psychologist.  When there was 
disagreement about an onset category they came to an agreement through 
discussion. In his study of CFS in an adolescent sample, Bell (1995) defined 
sudden/acute onset as an “abrupt onset of constant and debilitating fatigue that 
could be dated to a specific event or illness” (p. 45). He described all other onset 
patterns as gradual. Zheng et al. (2000) utilized a very specific definition of acute 
infectious-like onset, defining it as occurring over a period of no longer than 48 
hours. Mawle et al. (1997) evaluated sudden versus gradual onset CFS groups and 
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defined sudden onset as “flu-like” and abrupt, over the course of one to two days. 
Similarly Reyes et al. (1999) described sudden onset as occurring over “a few 
days” and gradual onset simply as “gradual.” Similar to Deluca et al. (1997), 
Cukor, Tiersky, and Natelson (2000) defined gradual onset as a “slow progression 
of symptoms over a period of weeks to months or greater “ and sudden onset as a 
“viral-like illness with a specific date of onset from which the patient did not 
recover” (p. 37).  Others simply state that individuals with CFS were grouped by 
sudden versus gradual onset without providing any description of how sudden and 
onset groups were determined (Nisenbaum et al., 2003). Based on much of the 
research presented above, there appear to be more specific definitions of acute or 
sudden onset groups; whereas, gradual groups are often seen as an ‘other’ onset 
category for onset types that cannot be clearly dated or defined. There does not 
seem to be any research in the field regarding possible complexities or differences 
in gradual onset patterns. 
Etiology 
Onset is considered an important focus of study as it might provide insight into 
the etiological factors that precede the development of ME and CFS. Numerous 
studies have investigated links between ME and CFS and potential etiological 
factors including infections and viruses such as Epstein-Barr virus (EBV; Holmes 
et al., 1987; Jones et al., 2004; Lerner, Zervos, Dworkin, Chang, & O'Neill, 1997; 
Levine, 2001; Sairenji, Yamanishi, Tachibana, Bertoni, & Kurata, 1995; Wallace, 
Natelson, Gause, & Hay 1999; White et al., 1995; Zhang et al., 2010), human 
herpesvirus-6 (HHV-6; Ablashi et al., 2000; Chapenko et al., 2006; Di Luca et al., 
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1995; Levine, 2001; Levine, Eastman, & Ablashi, 2001; Sairenji et al., 1995; 
Wallace et al., 1999; Yalcin, Kuratsune, Yamaguchi, Kitani, & Yamanishi, 1994), 
HHV-7 (Chapenko et al., 2006; Di Luca et al., 1995; Levine et al., 2001; Sairenji 
et al., 1995; Wallace et al., 1999), HHV-8 (Levine, 2001; Levine, Eastman, & 
Ablashi, 2001), enteroviruses (Chia, 2005; Chia & Chia, 2008; Chia, Chia, 
Voeller, Lee, & Chang, 2010; McArdle et al., 1996; Swanink et al., 1994; Zhang 
et al., 2010), and human cytomegalovirus (HCMV; Beqaj, Lerner, & Fitzgerald, 
2008; Levine, 2001; Wallace et al., 1999). ME and CFS has also been linked to 
blood transfusions (De Meirleir, De Becker, & Campine, 1999), chlamydia 
(Levine, 2001; Nicolson et al., 2000) and mycoplasmal infections (Nicolson, 
Nasralla, Haier, & Nicolson, 1998). Studies have shown possible links between 
CFS and parvovirus B19 (Kerr, Cunniffe, Kelleher, Bernstein, & Bruce, 2003), 
Coxiella burnetti (Zhang et al., 2010), and an increased number of D Lactic acid-
producing intestinal bacteria  (Sheedy et al., 2009). The results of these studies are 
mixed and there is still not conclusive evidence to provide a causal link between a 
virus/infection and the development of CFS. Research has also produced evidence 
for immune dysfunction and damage to the central nervous system (CNS; 
Broderick et al., 2010). Specifically, studies have found evidence for reductions in 
natural killer cell signaling and function, abnormal growth factor profiles, 
decreased neutrophil respiratory bursts, and an increased production of T-helper 
type 2 (Th-2) cells (Broderick et al., 2010; Cameron, Hirschberg, Rosenberg-
Hassan, Ablashi, & Lloyd, 2010; Carlo-Stella et al., 2006; Fletcher, Zeng, Barnes, 
Levis, & Klimas, 2009; Fletcher et al., 2010; Klimas, Salvato, Morgan, & 
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Fletcher, 1990; Lorusso, Mikhaylova, Capelli, Ferrari, Ngonga, & Ricevuti, 2009; 
Mihaylova, DeRuyter, Rummens, Bosmans, & Maes, 2007). Additionally, there 
has been evidence for a link between CFS and chemokines and T lymphocytes, as 
well as a dysregulation of the antiviral ribonuclease L (RNase L) pathway (De 
Meirleir  et al., 2000; Nijs, De Meirleir,  Meeus,  McGregor, & Englebienne, 
2004; Nijs, & Frémont, 2008;  Snell, Vanness, Strayer, & Stevens, 2005; 
Suhadolnik et al, 1997). Jason, Porter, Herrington, Sorenson, and Kubow (2009) 
have also presented evidence for the role of kindling to the limbic-hypothalamic-
pituitary axis as well as oxidative stress in the development and maintenance of 
ME and CFS.  
In addition to biological causes, researchers have investigated the link 
between stressful life events and the development of ME and CFS. Specifically, 
some research has found evidence that individuals with CFS experience a higher 
number of stressful life events prior to their illness onset compared to matched 
controls (Hatcher & House, 2003; Salit, 1997; Theorell, Blomkvist, Lindh, & 
Evengård, 1999). For instance, Salit (1997) found that in 39% of a CFS sample, a 
non-infectious event was reported as occurring prior to illness onset, and these 
non-infectious events included trauma (e.g. a car accident), allergic reactions, and 
surgery. A case-control study by Hatcher and House found that individuals with 
CFS reported more stressful events and difficulties three months and one year 
prior to the development of CFS (2003). In another case-control study, Theorell et 
al. (1999) found that individuals with CFS were almost twice as likely to report a 
negative event within the three months prior to the development of CFS compared 
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to a control group.  Salit (1997) and others have suggested that the cause of CFS 
is multi-factorial in nature and that a virus or other type of infection may trigger 
CFS after a person has experienced multiple stressful events.  
ME and CFS Onset Subtypes  
 Many researchers have suggested that mode of illness onset is 
potentially important for sub-typing individuals with ME and CFS (DeLuca et al., 
1997; Jason et al., 2005; Levine, 1997). Onset type may be associated with a 
variety of factors including etiology, illness severity, prognosis, psychopathology, 
and symptom profiles.  
Onset and Etiology 
Some researchers have sought to make a connection between onset type 
and etiological factors. For instance, a sudden/acute onset of symptoms following 
previously good health has been associated with a viral or infectious onset 
(Komaroff, 1988, 1994; Hay & Jenkins, 1994). Salit (1997) investigated both 
biological and environmental precipitating factors for CFS and found that in 72% 
of the study sample CFS symptoms developed following an acute infectious 
illness, involving the presence of distinct flu-like symptoms including a fever, 
malaise, headaches, and respiratory difficulties. Participants reported that their 
experience of fatigue became apparent after the flu-like symptoms dissipated.  An 
infection (EBV-2; B. burgdorferi-2; B. abortus-1; Influenza-l; Herpes simplex-1 
and Herpes zoster-1) was found in only 23% of participants reporting an 
infectious onset.  
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 Researchers in the field have examined the presence of stressful life events 
prior to the onset of CFS (Ray et al., 1995; Salit, 1997; Theorell et al., 1999). Salit 
found that those with an acute and clearly defined precipitating event (e.g. 
infection) had an equal number of stressful life events as those in the gradual 
group prior to the development of CFS (1997). When compared to controls, 
individuals with CFS, regardless of onset status, reported a higher number of 
stressful life events prior to CFS onset. In contrast to Salit’s findings (1997), 
MacDonald et al., (1996) did not find an increase in life stress in the year before 
the onset of CFS. Salit has suggested that multiple factors are responsible for the 
development of CFS (1997), and if just one factor was contributing to the 
development of CFS, the types of symptoms and the mode of onset would be 
more uniform.  
Onset and Prognosis 
 Some studies have found that patients with an acute onset may have a 
better prognosis than those with gradual onset (Levine, 1997; Masuda Nakayama, 
Yamanaka, Koga, & Tei1., 2002a; Salit, 1997). However, findings are mixed 
regarding the extent to which illness onset is predictive of prognosis in individuals 
with CFS. Jason et al. (2000) found that sudden illness onset was associated with 
poorer outcomes compared to those with a gradual onset. Reyes et al. (1999) 
found that over time, symptom patterns among individuals in the sample became 
more similar for those with sudden and gradual onset and that probability of 
recovery was not affected by mode of onset. Hill et al. (1999) also found that 
mode of illness onset was not predictive of a positive or negative illness outcome.  
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Njoke, Jason, Porter, and Brown (2009) reported that individuals with a sudden 
illness onset had significantly lower physical functioning and higher fatigue 
severity compared to those with gradual illness onset. 
Some researchers have investigated whether there is an interaction effect 
for mode of illness onset and psychiatric comorbidity in predicting health 
outcomes including symptom severity and functioning. Specifically, Njoku, 
Jason, Porter, and Brown (2009) examined mode of CFS onset and psychiatric 
comorbidity and found that those individuals with a sudden illness onset and 
without psychiatric comorbidity had higher rates of fatigue severity and more 
physical impairment than those with sudden illness onset plus psychiatric 
comorbidity. Furthermore, they found that those with a gradual illness onset plus 
psychiatric comorbidity demonstrated higher fatigue severity.  
Onset and Psychopathology 
  Jason et al. (2005) suggest that individuals with CFS often experience a 
sudden onset, which helps to differentiate the illness from depression, which more 
often is characterized by a gradual progression. In support of this assertion, 
DeLuca et al. (1997) found that individuals with CFS who experienced a gradual 
onset had significantly higher occurrences of Axis I, psychiatric diagnoses than 
those with an acute onset. Also in congruence with DeLuca and colleagues 
(1997), Salit (1997) reported that those with an acute CFS onset were less likely 
to endorse depressive symptoms. Johnson et al. (1999) suggested that there might 
two different CFS subgroups; one with sudden onset, without psychopathology, 
and with serious cognitive impairments, and the other with a slow or gradual 
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onset of symptoms, psychiatric comorbidity, and mild cognitive impairment. 
Other researchers have not found any evidence that sudden versus gradual onset 
groups differentiate based on psychopathology (Cukor, Tiersky, & Natelson, 
2000).  When examining a community-based sample of individuals with CFS, 
Jason et al., (2000) found that sudden onset of illness was associated with higher 
rates of psychiatric co-morbidity. Reyes et al. (1999) also examined a community-
based sample of individuals with CFS and found higher rates of depression in the 
sudden onset group.   
 Others have examined personality factors associated with mode of CFS 
onset. For example, Masuda et al. (2002b) found the individuals who experienced 
a non-infectious (non-acute) onset were what they described as “more neurotic,” 
had more chronic stress, and had more family related difficulties than individuals 
who experienced an infectious/acute CFS onset.  Masuda et al., (2002b) found 
that those who developed CFS following an acute infection were more likely to be 
social and were characterized as extroverts. 
Onset and Somatic Symptoms 
 In an epidemiology study, Reyes et al. (1999) compared sudden versus 
gradual onset groups for symptoms present at onset and they found that in the 
sudden onset group, individuals reported significantly more problems with 
symptoms related to infection, including sore throats, tender lymph nodes, chills, 
as well as difficulty thinking or concentrating, and hypersomnia. Similar to 
findings by Reyes et al (1999), in their randomized community-based sample, 
Jason, Taylor, et al. (2000) found that those with CFS who experienced a sudden 
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onset were more likely to endorse more severe sore throat pain and increased 
fatigue after exercise.  DeLuca and colleagues (1997) found that individuals with 
CFS, regardless of onset, had significantly more cognitive difficulties compared 
to healthy controls; however, individuals in the sudden group did not differ 
significantly from the gradual group. In a co-twin control study including 22 pairs 
of monozygotic twins, in which one twin met diagnostic criteria for CFS and the 
co-twin was healthy, Claypoole and Noonan (2007) found that of the co-twins 
with a CFS diagnosis, those with a sudden onset had slowed information 
processing on a neuropsychological assessment compared to those with a more 
gradual onset. Other studies however have not demonstrated higher levels of 
somatic complaints in either sudden or gradual onset groups (Cukor et al., 2000).  
Onset and Classification 
Mode of illness onset may also be useful in differentiating ME and CFS 
from illnesses that have some overlapping symptoms, including severe fatigue. 
Linder et al. (2002) used neural networks to classify patients with chronic fatigue 
syndrome, idiopathic chronic fatigue, lupus erythematosus, and fibromyalgia. 
Linder et al. (2002) attained 95% accuracy in correctly identifying individuals 
with their given diagnosis (sensitivity) and 85% accuracy in correctly identifying 
individuals who were negative for a specific diagnosis (specificity). Symptoms 
that had the highest differentiating accuracy for CFS were those with an acute 
onset and sore throats.  Furthermore, and as mentioned previously, it has been 
suggested that a sudden onset can help differentiate individuals with CFS from 
those with primarily depression (Carruthers et al., 2003; Jason et al., 2005) and 
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those with a psychosomatic disorder (Carruthers et al., 2003), as these often 
involve a slower and more gradual onset. 
Chronic Illness Narratives 
 The onset of chronic illness has been described by medical sociologists as 
a ‘Critical Situation’ (Giddens, 1979), a ‘Biographical Disruption’ (Bury, 1982), 
and a ‘Turning Point’ (Charmaz, 1991) in the lives of affected individuals. 
Charmaz suggests that individuals experiencing chronic illness learn to partition 
their lives in a variety of ways, such as separating their ill periods from their 
healthy periods, their periods of crisis from periods of calm, and their periods of 
symptom intensity with periods of remission. She asserts that significant events in 
an individual’s illness experience become “timemarkers” that are then placed 
within a meaningful illness chronology (1991; p. 57). Roth (1963) discussed the 
tendency of people to use illness experiences as a way to partition the phases of 
their lives and to mark time. Furthermore, Roth suggests that even in a period of 
crisis or uncertainty within the illness experience, people are able to note 
timemarkers and place them within their illness chronology (1963). Charmaz also 
describes timemarkers as significant events or “anchor points” (p. 198) that 
individuals use to evaluate their health status at any given time. The way in which 
individuals chronicle their illness allows for the discernment of significant events, 
durations, places, and people within their illness trajectory. She also asserts that 
adverse experiences within the illness chronology are experienced and recounted 
repeatedly. While the re-experience of these negative experiences are likely 
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stressful to the individual, Charmaz suggests that it allows people to identify 
nuances about their experience that were previously unnoticed (1991).   
 Charmaz (1991) discusses the utility of medical references and textbooks 
in outlining typical disease progression, as they allow individuals experiencing 
chronic illness to anticipate and compare phases in their illness development. 
However, she points out the difficulty in specifying illness progression when the 
onset is unknown. She also suggests that individuals who do not have a formal 
diagnosis for their illness and who experience indistinct symptoms may have 
illness chronologies that focus on the difficulties they experience with physicians 
and health professionals who have failed to validate their illness experience. 
Charmaz describes how chronic illness can unfold gradually and individuals may 
not notice that anything is wrong until they experience reductions in their ability 
to function (1991).  This suggests that the development of illness may influence 
one’s ability to discern a precise onset. Nonetheless, Charmaz emphasizes that the 
construction of illness chronologies can allow individuals to notice illness 
patterns, such as beginning symptoms or signs of the illness that others cannot 
(1991). The varied experiences apparent in the unfolding of chronic illness (slow 
and gradual versus sudden and distinct) as well as the tendency of individuals to 
actively chronicle their illness over time, provides compelling rationale for the 
importance of using personal illness narratives as a means of gaining rich 
information about this critical phase of illness emergence.  
 Individuals tell stories about their lives as a way to make sense of their 
experiences (Lieblich, Tuval-Maschiach, & Zilber, 1998). The transactional 
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model proposed by Lazarus and Folkman (1984) is based on the assumption that 
an individual’s cognitive appraisal of their experiences is influenced by 
characteristics of the person (e.g. their beliefs and commitments), his or her 
environment, and the interaction of the two. Conditions in the environment can 
influence the saliency and duration of an event. According to Lazarus and 
Folkman, person characteristics combined with environmental factors are 
integrated to form an appraisal (1984). Individuals reconstruct their experiences 
through this integrative form of cognitive appraisal, and although the 
reconstructed experience may not be purely objective, it is a representation of an 
individual’s experiences and their attempt to find meaning and coherence 
(Gilbert, 2002; Lee & Poole, 2005).  
Charmaz (1991) and many others have utilized personal narratives as a 
way to learn more about the experience of chronic illnesses including rheumatoid 
arthritis (Brown & Williams, 1995), multiple sclerosis (Reynolds & Prior, 2003), 
systemic lupus erythematosus (Taïeb, et al., 2010), HIV (Ezzy, 2000), chronic 
obstructive pulmonary disease (Bailey, 2001), cancer (Lee, 2001), and CFS 
(Hughes, 2002; McCue, 2004).  
Qualitative Assessment of Chronic Illness Onset 
 In-depth qualitative inquiry of the initial stage of chronic illness 
development from the patients’ perspective has been considered a useful approach 
for examining a variety of illness experiences. Some specific studies include those 
investigating the early symptoms of lung cancer (Corner, Hopkinson, 
Fitzsimmons, Barclay, & Muers, 2005), the trajectory of general stroke onset 
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(Kirkevold, 2002), narrative descriptions of sudden stroke onset (Faircloth, 
Boylstein, Rittman, & Gubrium, 2005), factors related to the onset of generalized 
osteoporosis in women (Okma- Keulen & Hopman Rock, 2001), and 
investigations of symptoms, time course patterns and contributory factors 
associated with heart failure (Schiff, Fung, Speroff, & McNutt 2003). These 
authors suggest that an in-depth analysis of chronic illness onset can provide 
insight into varied onset experiences, potential contributory and exacerbating 
factors, ways to improve methods for early illness detection, as well as 
intervention, treatment, and early prevention efforts.  
Qualitative Assessment of ME and CFS Onset 
Researchers in the ME and CFS field have also utilized a qualitative 
approach to better understand a variety of experiences related to ME and CFS, 
including the experience of illness onset. One study by McCue (2004) examined 
the illness narratives of 14 women who had reported significant improvement or 
total recovery from CFS. McCue (2004) investigated the personal experiences of 
illness onset that these women recounted, which included their difficulties 
receiving a diagnosis, the lack of attention to physical symptoms by their doctors, 
the tendency to assume a psychological etiology, and the significant stigma they 
experienced by the medical community.  
Reconstructing Events of ME and CFS Onset 
 Others have investigated illness narratives of ME and CFS onset with an 
emphasis on how people account for the initial unfolding of their illness in terms 
of patterns of onset and the perceived etiological factors and stressful events that 
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co-occurred with onset (Ray et al., 1998). Ray et al. (1998) interviewed 60 adults 
out of a larger subset of 147 adults who met the Oxford Criteria (Sharpe et al., 
1991) for CFS and asked them to describe their illness onset. Ray et al. (1998) 
prompted participants by asking whether they had a gradual or sudden onset and 
asked them to describe in detail their onset duration as well as perceived 
contributory factors.  Additionally, they interviewed participants with the shortest 
illness durations as well as individuals with the longest illness durations to 
investigate how illness length impacts their perception of onset and contributory 
factors. Interviews were coded for perceived contributory factors as well as how 
participants perceived the early development of their illness. The authors reported 
that the designated coders focused on how participants described their initial 
illness progression and they did not limit their coding to the terms “sudden” or 
“gradual.” Three separate groups of participants were identified when coding for 
CFS onset. One group was characterized by a gradual onset of CFS in which there 
was a slow, worsening of symptoms over time, culminating into the attribution 
that the illness was serious (n=15). A second group was identified as having an 
acute onset, which was characterized by a sharp increase in symptoms (n=31). 
Lastly, a third group was identified as having a two-phase illness onset, which 
began with a sharp deterioration and subsequent improvement in phase one, that 
was then followed by another deterioration of symptoms in phase two (n=14).  
Ray et al. (1998) examined differentiating themes across the onset groups 
and found that individuals in the gradual onset group attributed their illness to an 
infection or a series of infections, antibiotics, and the immune system “breaking 
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down.” More complex accounts included a combination of infection, 
overexertion, and stress. The sharp onset group described a clear transition 
between health and becoming ill, and one participant described going “down with 
a bang” (p. 103).  Individuals in the sharp onset group listed similar contributory 
factors as the gradual group. The phased onset group largely reported that an 
infection was the trigger of their illness. Within this group, one participant 
reported that “there was a gap and then it re-appeared” (p. 104).  In 11 cases, a 
worsening of illness was attributed to “overdoing things” (p. 104).  Some reported 
a failure to allow themselves time to recover. Additional findings by Ray and 
colleagues (1998) revealed strong and significant associations between illness 
duration and onset characteristics, as longer duration of illness (56-72 months) 
was associated with a gradual onset, and shorter duration (seven to 22 months) of 
illness was associated with sudden onset.  This suggests illness duration can 
influence an individuals’ representation of their onset pattern.  
Phases of Chronic Illness and the Fennel Phase Theory of CFS 
Stage models have been proposed to describe the progression of chronic 
illness, always beginning with an initial, onset stage.  One stage model developed 
by Rest (1971) suggests that chronic illness patterns involve the progression 
through distinct stages within a developmental sequence. Stages are hierarchical 
under this model, which assumes that an individual progresses through the stages 
in a successive manner so that each stage builds on a previous stage. Another 
stage model developed by Kubler-Ross (1969) proposes stages of illness that are 
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not discrete or in any hierarchical and fixed sequence. The stages in the Kubler-
Ross model (1969) can overlap and be experienced in any order.   
Fennell (1995) has applied a model of stage theory to describe the 
experience of CFS. Fennell proposed a phase model of CFS in which individuals 
living with the illness progress through four different stages of coping. The initial 
phase of Fennel’s model involves the “crisis mode” immediately following the 
onset of the illness. Fennel describes this stage as the period in which an 
individual experiences the initial emotional trauma of the emerging illness. Phase 
two of the model involves continued disruption and disorder followed by a 
stabilization of symptoms. Subsequently, phase three involves a sense of 
resolution by the sufferer, in which an acceptance of the chronic nature and 
ambiguity of CFS is more or less accepted by the individual. Lastly, phase four is 
described as a period of “integration” in which a person is able to integrate their 
pre-illness identity with their post-illness identity (1995).  
Fennell’s phase theory of CFS is aligned with Kubler-Ross' theory of 
death and dying, as it describes the experience of CFS and other chronic illnesses 
as continuous and cyclical in nature, such that individuals do not necessarily 
experience phases in a fixed order. Fennell proposed stage theory as a way to 
describe the progression that individuals take in their ability to cope with and 
come to terms with the illness; however, stage theory may also be beneficial for 
identifying the specific events and characteristics that define these stages, 
including factors related to symptom and stage duration, emerging symptoms, and 
illness-related consequences such as a loss of functioning.  
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Jason et al. (1999; 2000) utilized factor analytic methods to evaluate an 
instrument designed to measure the phases experienced by individuals with CFS 
(Fennell Phase Inventory; FPI) and found evidence of three distinct factor scores 
that adequately characterized the Crisis, Stabilization and Integration phases 
proposed by Fennell. Furthermore, the three factor scores were utilized in a 
cluster analysis, which resulted in four distinct clusters that reflected the four 
Fennel phases: Crisis, Stabilization, Resolution, and Integration. The development 
of the FPI and the empirical support for distinct phases of CFS has allowed a 
more in-depth look at the psychological and physiological processes occurring at 
these different phases. Reynolds, Brown, and Jason (2009) explored how the FPI 
was related to physical and psychological functioning and coping style. Results 
showed that individuals in the crisis phase had poorer functioning related to 
depression, quality of life, mental functioning, anxiety, and self-efficacy, as well 
as less adaptive coping styles. Those in the resolution phase maintained the most 
adaptive coping strategies. Fennell described distinct phases of CFS-related 
coping and adaptation. It is possible that Fennell’s phase theory can provide a 
theoretical foundation for documenting and evaluating the experience of CFS 
onset beyond just coping and adaptation. Other factors that may provide insight 
into this initial period of illness development may include bodily 
sensations/somatic symptoms, functional disability, and duration. 
Rationale 
ME and CFS are a complex and debilitating illness without a conclusive or 
universally accepted etiology. It has been suggested that the ME and CFS label 
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involves multiple illness types with both distinct and overlapping features, and 
this is problematic for classifying individuals based on common features (Jason et 
al., 2005). Due to the heterogeneity of the illness, it has been suggested that there 
may be subtypes of people within the ME and CFS diagnostic construct (Jason et 
al., 2005). One potentially important factor for differentiating people with ME and 
CFS is mode of illness onset; specifically, whether the illness developed in a 
sudden or a gradual manner (DeLuca et al., 1997; Jason et al., 2005; Levine, 
1997). The mode of ME and CFS onset may differentiate individuals on key 
factors including etiology, prognosis/health status, and psychopathology. For 
instance, previous research has demonstrated a potential link between sudden CFS 
onset and a viral/infectious etiology (Komaroff, 1988, 1994; Hay & Jenkins, 
1994; Salit, 1997). Sudden CFS onset has also been associated with a lower 
prevalence of psychopathology prior to onset, compared to gradual onset patterns 
(DeLuca, Johnson, Ellis, & Natelson, 1997; Johnson et al. 1999; Salit, 1997). 
Additionally many have theorized a possible link between mode of illness onset 
and health status.  Some studies have found that patients with a sudden onset have 
a better prognosis than those with gradual onset (Levine, 1997; Masuda 
Nakayama, Yamanaka, Koga, & Tei1, 2002a; Salit, 1997), while others have 
found that sudden illness onset was associated with poorer outcomes related to 
physical functioning (Jason et al., 2000), as well as symptom presence and 
severity (Deluca et al., 1997; Jason et al., 2000; Njoke et al., 2009; Reyes et al., 
1999) compared to those with a gradual onset. These findings are mixed and some 
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researchers have failed to find a link between CFS onset and prognosis (Hill et al., 
1999; Reyes et al., 1999).  
There continues to be controversy in the field with regard to the mixed 
evidence linking CFS onset with etiology, prognosis, and psychopathology. 
Additionally, the samples used in past studies were small; therefore, more 
research in this area with larger study samples is necessary.  In an effort to build 
on previous work, the current study serves as an investigation into whether those 
with a sudden illness onset are differentiated from those with a gradual onset on 
these key factors. Based on previous research linking CFS sudden onset with an 
infectious etiology, poorer health outcomes, and lower psychiatric comorbidity, it 
is expected that those with a sudden onset will more likely report that a virus or 
infection preceded ME and CFS, will more likely attribute their illness to physical 
causes, will have lower lifetime psychiatric comorbidity, poorer physical 
functioning outcomes, and better mental health outcomes compared to those with 
a gradual onset.  
Given the ambiguous etiology, complex symptom profile, and the 
heterogeneous onset patterns associated with ME and CFS, it would be useful to 
better define the earliest stage of the illness. Fennell’s Phase Theory (1995) 
describes four stages of adaptation and coping associated with the progression of 
ME and CFS. It is possible that a closer investigation of the Crisis phase (i.e. time 
of onset) may allow for the operationalization of this initial phase by identifying 
and clearly defining early symptoms and signs of ME and CFS, as well as the 
potentially varied patterns at onset, duration of onset, and the extent of functional 
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disability experienced in this early crisis phase. In order to fully capture the 
experience of onset, it may be crucial to interview those who are most directly 
affected by the illness; the patients themselves. Roth (1963) suggests that even in 
a period of crisis or uncertainty during the illness experience, people are able to 
note timemarkers and place them within their illness chronology. Charmaz (1991) 
suggests that illness narratives allow for the identification of nuances of the illness 
experience that may otherwise not be captured. Illness narratives have also been 
used to better understand a variety of illness experiences as well as CFS (Hughes, 
2002; McCue, 2004). 
To this author’s knowledge, there are only a small number of studies that 
have utilized illness narratives for the purpose of examining the initial onset 
period of CFS. McCue (2004) investigated personal experiences related to stigma 
and diagnostic difficulties and Ray et al. (1998) conducted qualitative interviews 
with individuals with CFS and identified the presence of three onset types 
(sudden, gradual, and phased). The evidence for three onset types suggests that 
onset may be more complex than the dichotomous way it is often classified in the 
literature (e.g. sudden versus gradual).  A more in-depth look at this early stage of 
CFS may provide insight into how individuals with CFS account for and describe 
their illness onset. Based on previous research documenting the rich information 
that can be gained from personal narratives of illness experience, the current study 
involved interviews with individuals with CFS to determine how they describe 
their illness onset.  
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In sum, a close evaluation of onset patterns of CFS may provide insight 
into whether mode of illness onset is useful in sub-typing individuals on key 
factors related to etiology, psychological factors, and prognosis. Furthermore, an 
in-depth look at CFS illness narratives can illuminate the onset experience, which 
can help with the further operationalization of the initial crisis phase proposed by 
Fennel. Operationalization of this early phase of illness could lead to more 
consistency in how onset is described and documented in the literature, and could 
also improve our methods for assessing this potentially crucial time period in the 
development of ME and CFS. Lastly, a more-in-depth examination of ME and 
CFS onset patterns may lead to more effective methods for early detection of this 
devastating illness. 
Statement of Hypotheses and Research Questions 
Hypothesis I.  Individuals with a sudden ME and CFS onset (24 hours to 1 month) 
will more likely report that an infection or virus preceded their fatigue/energy 
problems than individuals with a gradual onset (2-6 months to 3+ years). 
 
Hypothesis II. Individuals with a sudden ME and CFS onset will more likely 
report that the cause of their fatigue/energy problems is “Definitely Physical” or 
“Mainly Physical” than individuals with a gradual onset. 
 
Hypothesis III. Individuals with a sudden ME and CFS onset will evidence higher 
role emotional (role limitations due to personal or emotional problems) and 
mental health functioning than individuals with a gradual onset. 
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Hypothesis IV. Individuals with a sudden ME and CFS onset will have lower 
rates of lifetime psychiatric comorbidity than individuals with a gradual onset.  
 
Hypothesis V. Individuals with a sudden ME and CFS onset will evidence lower 
physical and role physical functioning than individuals with a gradual onset.  
 
Research Question I. How do individuals with ME and CFS describe their illness 
onset, specifically with regard to the early days, weeks, or months in which their 
illness emerged? 
Method 
Research Participants and Procedures 
 The current study involved two phases. In the first phase, participants 
completed the DePaul Symptom Questionnaire (DSQ), a survey that assesses 
demographic information, ME and CFS symptomatology, and illness history. In 
the second phase of the study a subset of phase one participants were asked to 
complete a semi-structured phone interview regarding their illness onset.  
  Phase one. An international convenience sample of adults self-identifying 
as having CFS, ME/CFS, or ME was recruited (Jason, Brown, Evans, Sunnquist, 
& Newton, 2013; Jason, Sunnquist, Brown, Evans, & Newton, 2014). In order to 
be eligible, individuals had to be at least 18 years old, capable of reading and 
writing English, have a self-reported current diagnosis of ME, CFS, or ME/CFS, 
and meet the Fukuda et al. (1994) case criteria for CFS. Following approval by 
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DePaul University’s Institutional Review Board, participants were recruited from 
a variety of sources including postings on internet forums and support group 
visits. Additionally, some participants who participated in previous studies 
conducted by the DePaul research team or who emailed the research team’s email 
address with an interest in participating in future studies were re-contacted.  
 Participants were given three options for completing the surveys: an 
electronic survey, a hard-copy survey, or a verbal survey over the telephone. All 
participants were given the opportunity to complete these surveys at home or in 
person at the Center for Community Research at DePaul University. Participants 
were not given a timeline for survey completion, as this illness can be fluctuating 
in nature, and a rapid decline of functioning can occur on any given day. The first 
100 individuals who completed the survey received a $5.00 gift card to 
Amazon.com for their participation. 
 Of the original 217 individuals who completed the DSQ, 181 participants 
were included in the present study. Twenty-eight participants were excluded due 
to active medical conditions, active psychological conditions, and/or the 
endorsement of lifelong fatigue, all of which preclude a diagnosis of CFS based 
upon the Fukuda et al. (1994) case definition. Seven participants were excluded 
due to not meeting full criteria for Fukuda et al. (1994). One participant did not 
answer the question regarding onset duration and was excluded.  Although there 
was no formal psychiatric interview, Torres-Harding, Jason, Cane, Carrico, and 
Taylor (2002) have demonstrated that individuals with CFS are capable of validly 
self-reporting psychiatric comorbidity information. 
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 Demographically, the sample of 181 participants was 83.3% female and 
16.7% male. 97.8% of the sample identified as Caucasian, 0.6% as Asian or 
Pacific Islander, and the remaining 1.6% identified as “Other.” Of those 
participants who identified as “Other”, three participants identified as Hispanic or 
Latino origin, and one identified as multi-racial. One participant identified as 
American Indian or Alaska Native. With regard to marital status, 57.6% identified 
as married, 0.6% identified as separated, 18.1% identified as divorced, and 23.7% 
identified as never married. 43.5% of participants endorsed having children. 
55.6% of the sample stated that they were currently on disability, with only 11.7% 
of the sample working part or full-time. With regards to educational level, 40.0% 
of the sample held a professional degree, 35.0% held a standard college degree, 
17.8% attended college for at least one year, and 7.2% completed high school or 
had a GED. The mean age was 51.53 (SD = 11.30). 
 Phase two. The second phase of the study involved qualitative interviews 
with a subset of the larger sample of 181 participants. A total of 14 adults were 
recruited from the larger sample. Participants in phase two were identified using 
stratified purposeful sampling (Patton, 2002) based on onset duration. Participants 
responded to an item on the DePaul Symptom Questionnaire (DSQ) that assesses 
onset duration (i.e. the period of time in which their illness developed). Possible 
responses included: within 24 hours, over one week, over one month, over two to 
six months, over seven to 12 months, over one to two years, and over three or 
more years. Two people from each of the seven onset duration categories were 
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recruited to participate in phase two of the study in order to incorporate a broad 
range of onset experiences. 
 All 14 participants (13 females and 1 male) identified as Caucasian, nine 
(64.3%) identified as married, two (14.3%) identified as divorced, two (14.3 %) 
identified as never married, and one individual (7.1%) left the marital status item 
blank. Six (42.9%) participants reported having children. With regard to work 
status, seven (50%) participants were on disability, one (7.1%) identified as a 
student, two (14.3%) identified as homemakers, one (7.1%) was retired, one 
(7.1%) identified as unemployed, and two (14.3%) reported that they were 
working part-time. With regard to educational level, four (28.6%) held a 
professional degree, six (42.9%) held a standard college degree, two (14.3%) 
attended college for at least one year, and two (14.3%) completed high school or 
had a GED. The mean age was 53.21 (SD = 9.31). 
 After receiving IRB approval, researchers emailed an IRB approved 
consent form to potential participants for phase two of the study. Participants who 
consented to the study were instructed to reply back to the email with the 
following message: “I consent to be in this study. I have received the attached 
document and after reading the document, I understand what will be asked of me 
during the study and I also understand my rights as a research participant.”  
 After informed consent was obtained, researchers scheduled the phone 
interview. Interviewers called participants’ cell phone or landline phone using the 
internet calling service Skype. The author/principle investigator (PI) and an IRB 
approved undergraduate student/research assistant from the Center for 
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Community Research at DePaul University served as interviewers. The author/PI 
trained the undergraduate research assistance on administration of the interview 
protocol and both participated in weekly meetings to review progress and to 
discuss any issues with scheduling or with the interview protocol.  
 At the start of the phone interview, the interviewers explained to 
participants that they would be asked to discuss their health and illness 
experiences. They were told that the interview would take approximately one hour 
to complete. Additionally, they were told that the interviewer would ask them 
follow up questions in order to obtain more detailed information about a particular 
experience or event. They were also reminded that they did not have to answer 
any question that they did not feel comfortable answering and they were reminded 
that they could take breaks at any time during the interview. Additionally, 
participants had the option of breaking up the phone interview into two separate 
interviews as the one-hour time commitment was too taxing for some. Participants 
were also encouraged to tell the interviewer or PI about any questions or concerns 
they had throughout the study period.  
 Following the initial introductory statement by the interviewer, 
interviewers asked participants which illness label (e.g. ME, ME/CFS, and CFS) 
they preferred to use when describing their illness. This label was then used 
throughout the interview. The first study question of the interview was open-
ended and read as follows: “Please tell me about the period of time when you first 
became sick with ME/CFS” (or CFS or ME depending on participants preferred 
illness label). Interviewers proceeded with an open-ended line of questioning (e.g. 
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“What else do you remember about that experience?”) in order to get rich, 
detailed information about participants’ perceptions of their onset period. The 
interview also included an open-ended question that read as follows: “Please tell 
me about the period of time before you became sick with ME/CFS” (or ME or 
CFS). Interviewers followed up further with an open-ended line of questioning in 
order to receive the most rich and detailed account possible from participants: 
“Please tell me about the year before you became sick with ME/CFS” and/or 
“Please tell me more about that experience.” The open-ended questioning was 
adapted for each participant’s unique illness experience; therefore, the interview 
protocol was semi-structured to allow for flexibility. 
 Following these open-ended questions, interviewers proceeded with more 
direct questioning for the purpose of filling in gaps of information that was not 
provided from the initial open-ended questions and for determining more 
objective measures of participants’ functioning and disability prior to and 
following the onset of the illness. Specifically, interviewers asked participants 
over what period of time their first symptoms developed and what year and month 
(if remembered) participants became first became ill with CFS. Interviewers 
asked participants to indicate their level of disability and functioning using a CFS 
Disability Scale (Bell, 1995) which was emailed to participants prior to the 
interview. The CFS Disability Scale is an 11-point scale with possible response 
values from 0-100, where 100 represents normal, fully active functioning, and 0 
represents severe disability/unresponsiveness (See description of this scale in the 
Measures section below). Participants were asked to rate their functioning level 
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during the time of onset or first sign of symptoms, prior to onset/first symptoms, 
and the period following onset/first symptoms. In addition to questions about 
functioning, interviewers asked participants to indicate which symptoms they may 
have experienced before, during and after onset. Furthermore, interviewers 
assessed for other significant personal, work, or other health related events that 
occurred during these timeframes.  Interviewers also asked participants to recall 
significant life events including holidays as well as information regarding the time 
of year (e.g. seasons) in order to aid participants’ recall of their functioning and 
symptoms at onset. These recall aids are a major component of the widely used 
and reliable Timeline Follow Back Interview method for the assessments of past 
alcohol use (Sobell & Sobell, 1992) and has also been used for the assessment of 
cancer patients’ retrospective recall of early symptoms before diagnosis (Corner, 
Hopkinson, Fitzsimmons, Barclay, & Muers, 2005). The interview allowed for 
considerable flexibility in questioning, as it was important for interviewers to ask 
questions based on each participant’s unique timeline and illness history.   
 Following completion of the phone interview, participants were debriefed 
on the purposes of the study and they were provided with contact information for 
any further inquiries. The audio-recorded phone interviews were transcribed 
verbatim and entered into the qualitative data analysis software program NVivo 
10.0 (QSR International, 2012).  
 Qualitative method. The qualitative approach for this study is based off 
of the principles of qualitative description (Sandelowski 2000; 2010). Qualitative 
description involves lower-inference interpretation compared to other qualitative 
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methods such as phenomenological approaches (Sandelowski 2000; 2010). 
Qualitative description has been identified as particularly useful in the health 
sciences and health care fields, in mixed-method designs, and for use with 
vulnerable populations (Neergaard, Olesen, Andersen, & Sondergaard, 2009; 
Sullivan-Bolyai, Bova, & Harper, 2005). Additionally, it has been described as an 
appropriate approach when the desired outcome is a rich description of a 
phenomenon, process, event, or experience. Furthermore, when using a qualitative 
descriptive approach, the researcher attempts to stay as close to the data as 
possible without over-interpreting the data from the perspective of the researcher 
(Neergaard et al., 2009; Sullivan-Bolyai et al., 2005; Sandelowski, 2000). 
Qualitative description is considered a useful approach for questionnaire/scale 
development, needs assessments, and for the development or improvement of 
treatment interventions (Sullivan-Bolyai et al., 2005). This naturalistic approach 
allowed for the rich description of the current study participants’ accounts of the 
early days, weeks, and months their illness.  
 The interview transcripts were analyzed using qualitative content analysis. 
The general analysis steps taken were based on an approach originally described 
by Weber (1985) and also summarized by Zhang and Wildemuth (2009). 
Following full transcription of the audio-recorded interviews, the unit of analysis 
was identified. The interview text was coded by themes, which were expressed in 
words or phrases. The analysis began with reading and re-reading the interview 
text in order to gain a full sense of the data.  During initial thematic analysis, key 
words and phrases were identified using an “open coding” approach (Corbin & 
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Strauss, 2008, p. 160) in order to allow for patterns and themes of onset 
experience to emerge from the data (Patton, 2002). The text was read repeatedly 
this way in order to define and develop categories that were included in the 
coding scheme.  This approach is consistent with the naturalistic inquiry that is 
characteristic of qualitative description (Sandelowski, 2000).  A coding manual 
was developed in order to clearly define and outline categories as they emerged 
and to enhance reliability across coders (Zhang & Wildemuth, 2009). The coding 
manual included definitions and rules for assigning categories to the text, and 
each category included examples of text from transcripts, as suggested by Weber 
(1990). Coding and category development was ended once the categories were 
deemed saturated and new information was no longer contributing to the 
development of new categories or to category refinement (Patton, 2002).   A 
three-stage method for establishing intercoder reliability and agreement 
(Campbell, Quincy, Osserman, & Pedersen, 2013) was used. In the first stage, the 
PI and second trained coder implemented the coding scheme on a randomly 
selected sample of transcripts and then calculated intercoder reliability.  In the 
second stage, coding disagreements were discussed and resolved through a 
negotiation process among the PI and the second coder, in order to establish a 
high level of intercoder agreement.  In the third stage, the PI then implemented 
the coding scheme on the remaining transcripts. Campbell et al. (2013) 
recommend this three-stage method for situations in which one coder has more 
expertise on the topic being investigated.  
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Participant responses to interview questions related to functioning/ability 
levels over time (using the CFS Disability Scale) were used to develop a visual 
graph of onset chronology, similar to the visual graphs created from the lifeline 
interview methods of Bourque and Back (1977). Lifeline interviews have been 
used to construct life timelines that require respondents to draw “up and down” 
lines that represent the positive and negative periods and events of their lives on a 
visual graph. Okma-Keulen and Hopman-Rock (2001) utilized and adapted the 
lifeline interview method in order to gain a richer understanding of characteristics 
associated with the onset of generalized osteoarthritis in women (2001). In 
traditional lifeline studies, the visual graphs are completed by the participant or 
co-constructed by the participant and interviewer. The current study involved 
phone interviews; therefore, this author completed the onset lifelines after the 
interviews with participants were completed. The “ups and downs” on the onset 
graph were graphed on the Y-axis and were constructed using the participants’ 
responses to disability/ functioning questions (participants responses using the 0-
100 disability scores that from the CFS Disability Scale) as well as their report of 
symptoms and significant life (personal and health) experiences.  The visual 
graphs are different than typical lifeline graphs, as they do not cover a person’s 
entire life course, rather they focus on the onset period, the year leading up to 
onset, and the time following the onset period. Some individuals’ histories began 
years before the onset and others began a year or a month prior to illness onset; 
therefore, the interview protocol and the visual graphs allowed for these 
differences in illness experience. The graphs were created using Microsoft Excel. 
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After the graphs were completed, they were emailed to the respondents in order to 
check for accuracy. Respondents had the opportunity to provide corrections by 
replying to the email with a list of corrections and/or additions to the graph, or 
they could provide their corrections over the phone by communicating to the 
author which aspects of the graph needed correction.  
 Following data analyses, this author emailed participants a summary of the 
major themes and key findings across the overall sample as well as copies of their 
individual illness timeline graphs. After the summaries were received, participants 
were provided the opportunity to provide their impressions of the overall themes 
and findings by replying to the authors’ email with thoughts and reflections or by 
opting to have a second 15-30 minute phone interview. The phone conversation 
was informal and allowed for a back and forth reflection between author and 
participant regarding the study and overall impressions.   
Measures 
 The first phase of the study utilized a broad measure of CFS 
symptomatology, demographic, and illness history, as well as a measure of 
functional disability. The second phase of the study included a semi-structured 
interview format, in which participants were asked questions related to their 
illness onset. The interview also included a measure of functional disability.  
 DePaul symptom questionnaire. All participants completed the DePaul 
Symptom Questionnaire (DSQ) (Jason, Evans, Porter et al., 2010), a self-report 
measure of CFS, ME, and ME/CFS symptomatology, demographics, and 
occupational, psychiatric, medical and social history. The DSQ was developed to 
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classify individuals on a variety of CFS, ME, and ME/CFS case definitions; 
however, the symptom list was based upon a revised approach to the Clinical 
Canadian criteria for ME/CFS (Carruthers et al., 2003). The DSQ includes 
questions related to CFS symptoms (including symptoms that preceded the CFS 
onset), diagnosis, treatments, and psychiatric/medical diagnoses. Participants are 
also asked to indicate whether they have family members with CFS. Additionally, 
participants are asked to identify the duration of their illness onset period, the 
degree to which their illness was caused by physical versus psychological factors, 
and specific difficulties related to energy, fatigue, and post-exertional malaise. 
The majority of items on the DSQ have evidenced good to excellent correlation 
coefficients, suggesting that the overall instrument is a reliable measure for 
examining symptoms and illness constructs within the patient community (Jason, 
Brown, Sunnquist, & Evans, 2014). For the purposes of the study, only questions 
that specifically assessed aspects related to onset duration, infectious events 
preceding CFS onset, psychiatric comorbidity, and illness attributions regarding 
the cause of illness were examined. These items are presented below in more 
detail.  
 Onset duration. Participants were asked to respond to the following 
question on an 8-point likert scale: “over what period of time did your 
fatigue/energy related illness, develop?” Possible responses include: 1= within 24 
hours, 2= over one week, 3= over one month, 4= over two to six months, 5= over 
seven to 12 months, 6= over one to two years, 7= over three or more years, and 
8= I am not ill. No participants endorsed that they were not ill. Jason, Brown, 
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Sunnquist, and Evans (2014) found that this item demonstrated excellent test-
retest reliability with a kappa coefficient of .76 when completed by individuals 
with ME and CFS.  
 Events preceding CFS onset. On the DSQ, participants were asked to 
indicate if they experienced a significant event prior to developing CFS. 
Specifically the item asks: “did your fatigue/energy related illness start after you 
experienced any of the following? (Check one or more and please specify)”: an 
infectious illness, an accident, a trip or vacation, an immunization, surgery, severe 
stress (bad or unhappy event), other, I am not ill. No participants included in the 
current study endorsed that they were not ill. This study will focus on responses to 
the infectious illness category of this item. Jason et al. (2014) found that this item 
category demonstrated excellent test-retest reliability with a kappa coefficient of 
.90. 
 Psychiatric comorbidity. With regard to psychiatric comorbidity, 
participants were asked the following questions: “Have you ever been diagnosed 
and/or treated for any of the following: Major depression, Major depression with 
melancholic or psychotic features, Bipolar disorder (Manic-depression), Anxiety, 
Schizophrenia, Eating Disorders, Substance Abuse, Multiple chemical 
sensitivities, Fibromyalgia, Allergies, Other (Please specify), No 
diagnosis/treatment. Participants are instructed to check all responses that apply 
and to also write in the year the condition was experienced, years it was treated, 
and medication if applicable. For the purposes of the current study, only responses 
involving psychiatric diagnoses were examined. Jason et al. (2014) found that this 
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item demonstrated excellent test-retest reliability with kappa coefficients ranging 
from .76 to .92 for psychiatric diagnoses as reported by individuals with ME and 
CFS. 
 Medical outcomes study short-form 36 survey (SF-36). All participants 
completed the SF-36 (Ware, Snow, & Kosinski, 2000), a 36-item self-report 
measure of disability comprised of eight subscales: physical functioning, role 
physical, bodily pain, general health, role emotional, social functioning, vitality, 
and mental health. The composite score for each subscale ranges from 0-100, with 
higher scores indicating better functioning. This measure is frequently used in 
research to assess disability brought on by illness. Buchwald, Pearlman, Umali, 
Schmaling, and Katon (1996) found that for a sample of individuals with CFS, the 
SF-36 had good internal reliability and convergent validity. It was also able to 
distinguish individuals with CFS and chronic fatigue from individuals with major 
depression, acute mononucleosis, and from healthy controls. 
 DePaul onset interview. A semi-structured interview was developed by 
this author and colleagues at the Center for Community Research at DePaul 
University (See Appendix A). The Interview includes open ended and close-
ended questions that ask participants to describe their illness onset and the year 
leading up to onset. The questionnaire also includes guidelines for assessing 
participants’ level of disability and functioning at onset, prior to onset, and 
following onset. For participants who are not able to identify a clear onset, 
interviewers asked participants about the period of time in which they 
experienced the first symptoms/signs of the illness.  The interview also assesses 
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any significant personal and health-related events, as well as symptoms 
experienced before, during, and after illness onset. The questionnaire allows for 
flexibility and for follow up questions in order to capture each participant’s 
unique illness timeline and to gain detailed information on onset and functioning.  
 CFS disability scale. The CFS Disability Scale (See Appendix B) was 
developed by Bell (1995) as a tool for physicians and other health clinicians to 
assess disability level and activity reduction. The CFS Disability scale is a 
modified version of the Karnofsky performance scale (Karnofsky, 1949), which 
was developed for the purpose of quantifying the functional status of individuals 
with cancer. Similar to the Karnofsky scale, the CFS Disability Scale is based on 
an 11-point scale from 0-100 (with 10 point increments), where 0= unresponsive 
and 100=fully active/normal. To this author’s knowledge there are no studies 
published that have examined the reliability and validity of the CFS Disability 
Scale. 
Results 
Phase One 
 Quantitative analyses were conducted in order to determine whether mode 
of illness onset (sudden versus gradual) differentiated individuals with ME and 
CFS on key factors related to etiology, psychological factors, and prognosis. 
For Hypothesis I, it was predicted that individuals with a sudden ME and 
CFS onset (24 hours to 1 month) would more likely report that an infection or 
virus preceded their fatigue/energy problems compared to individuals with a 
gradual onset (2-6 months to 3+ years).  Results of the Pearson’s chi-squared test 
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of independence revealed that the percentage of participants who reported that an 
infection preceded their illness did not differ by onset group, χ2 (1, N = 181) = 
1.10, p =.29 (see Table 1 for frequency and percentage by onset group).  
For Hypothesis II, it was predicted that individuals with a sudden ME and 
CFS onset would more likely report that the cause of their fatigue/energy 
problems is “Definitely Physical” or “Mainly Physical” than individuals with a 
gradual onset. Results of the Pearson’s chi-squared test of independence revealed 
that the percentage of participants who reported that the cause of their illness was 
“Definitely Physical” or “Mainly Physical”, did not differ by onset group, χ2 (1, N 
= 178) = .91, p =.34 (see Table 1 frequency and percentage by onset group). 
For Hypothesis III, it was predicted that individuals with a sudden ME and 
CFS onset would evidence higher role emotional and mental health functioning 
than individuals with a gradual onset. A multivariate analysis of variance 
(MANOVA) was performed to examine whether sudden onset mean scores on the 
Role Emotional and the Mental Health sub-scales of the SF-36 are significantly 
higher than the gradual onset mean scores. There was not a clinically significant 
main effect of onset group on mental health functioning; however, a trend was 
noted in the expected direction, F(2, 181) =2.89, p = .06 (see Table 2 for means 
and standard deviations by onset group).  
For Hypothesis IV, it was predicted that individuals with a sudden ME and 
CFS onset would have lower rates of lifetime psychiatric comorbidity than 
individuals with a gradual onset. The Pearson’s chi-squared test of independence 
revealed that the percentage of participants who endorsed at least one lifetime 
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psychiatric diagnosis did not differ by onset group, χ2 (1, N = 181) = .42, p = .52 
(see Table 1). 
 For Hypothesis V, it was predicted that individuals with a sudden ME and 
CFS onset will evidence lower physical and role physical functioning than 
individuals with a gradual onset. A multivariate analysis of variance (MANOVA) 
was used to examine whether sudden onset mean scores on the Physical 
Functioning and Role Physical sub-scales of the SF-36 are significantly lower 
than gradual onset mean scores. There was not a significant effect of onset group 
on mental health functioning, F(2, 180) = 1.33, p = .26 (see Table 2 for means and 
standard deviations by onset group) 
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Table 1 
Participants with Sudden Versus Gradual Onset Endorsing Viral Onset, Physical 
Illness Attribution, and At Least One Lifetime Psychiatric Diagnosis (N=181) 
 
 
 
 
Table 2  
Means and Standard Deviations on SF-36 Subscales by Onset Group (N=181) 
 
 
 
 
 
 
Phase Two 
 Qualitative analyses were employed in order to investigate how 
individuals with ME and CFS describe their illness onset, specifically with regard 
to the early days, weeks, or months in which their illness emerged. Intercoder 
reliability across two coders (the PI and an undergraduate level research assistant) 
was calculated on three randomly selected transcripts using the qualitative data 
analysis software program NVivo 10.0 (QSR International, 2012). After utilizing 
the three-stage method of establishing intercoder reliability and agreement as 
described by Campbell et al. (2013), the overall intercoder reliability was found to 
be excellent, with an average overall Kappa of 0.98 across the three coded 
 
DSQ Item 
 Sudden 
 (n=98) 
Gradual 
  (n=83) 
 
χ2 
 
p 
     %  (n)    %  (n)   
Infectious Onset  73.5 (72) 66.3 (55)  1.11 .29 
Physical Attribution  96.9 (93)  93.9 (77)  .91 .34 
Lifetime Psychiatric Dx  39.8 (39)  44.6 (37)  .42 .52 
 
SF-36 Subscale 
Sudden  
(n=98) 
Gradual 
(n=83) 
  M (SD) M (SD) 
Mental Health Functioning 74.35 (15.94) 68.80 (17.18) 
Role Emotional 84.35 (33.57) 75.10 (39.93) 
Physical Functioning 27.56 (18.56) 31.94 (18.03) 
Role Physical  4.08 (14.22)   5.79  (16.33) 
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transcripts.  
 A summary of themes can be found in Tables 3 and 4. Each theme’s 
meaning as it relates to the way in which participants described the onset and 
development of their illness is discussed below. The broad themes found in the 
analysis are as follows: onset/illness progression, illness cause, adapting and 
coping, hardworking, active lives prior to onset, healthy prior to onset, health 
problems prior to onset, comorbid health conditions, emotional response to onset, 
exertional effects, life limiting, stress, traumatic experiences, lack of support, 
support, and treatment limitations. The majority of themes include more specific 
subthemes and they are described in detail below.  Whenever a direct quote is 
used from a participant, the unique participant number (1 through 14) is attributed 
to that person as well as the period of time in which their illness developed (as 
reported on the DSQ onset duration item). The DSQ onset period is shown in 
parentheses directly following the participant’s number.    
 Onset/Illness Progression. Fourteen study participants described the 
period of time in which they first became ill. Different subthemes emerged within 
this larger theme of illness onset/illness progression. Descriptions of onset and 
illness progression were often described in conjunction with one another, and 
thus, they comprise one superordinate theme.  Below are the various subordinate 
themes that emerged from the larger onset/illness progression category. Notably, 
many participants were included in more than one category.  
Sudden. Seven participants described the onset of their illness as 
occurring suddenly and they used words such as “sudden,” “suddenly,” “rapidly,” 
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“overnight,” and “immediately.” A sudden illness onset was described by 
individuals who endorsed a range of onset periods on the DSQ including: 24 
hours (n=2), over 1 week (n=2), over one month (n=1), over 2-6 months (n=1), 
and over 3 or more years (n=1).   
Participant 4 (onset over 1 week) stated: “It was like something has 
suddenly happened.” 
Flipping a light switch. Two of the seven participants within the “sudden” 
category used the analogy of flipping a light switch to describe the experience of 
their sudden onset. For example, participant 11 (onset over 3 or more years) 
stated, “it was a sudden onset” and “so it really was like someone had flipped a 
light switch and made me sick and never switched it off.” 
Time. Three of the seven participants described their sudden onset in the 
context of time. Participant 3 (onset over 24 hours) stated: “my CFS came on 
suddenly” and “you know, it seemed overnight to me.” 
Participant 5 (onset over 1 month) described how her illness began 
suddenly following a case of gastroenteritis. She stated, “suddenly, in November, 
I had, this um, in a week's time, I had this gastroenteritis. The initial insult was a 
few days. I started feeling the gastroenteritis, you know, within a week I had to go 
to the ER.” 
Participant 10 (onset over 2-6 months) perceived her sudden onset as 
developing over a slightly longer time period than participant 5, stating, “very 
rapidly, over the series of like 2 months! Maybe 2 months at the most. I was 
normal and then I was sick.” 
 56	  
Exact date. Three participants were able to report the exact date of their 
illness onset. When asked about the period of time her first symptoms developed, 
Participant 3 (onset over 24 hours) stated, “It was April 29th, 2003.” 
Definitive turning point/downturn. Five individuals described a definitive 
turning point/downturn during the period of time that their illness developed. This 
was often described as a point in the illness development when their health and 
functioning took a clear turn for the worse and symptoms became significantly 
more severe and debilitating.  A definitive turning point was described by 
individuals who endorsed an onset period of one week (n=1), 7-12 months (n=2), 
and 1-2 years (n=2) on the DSQ.  
For Participant 1 (onset over 7-12 months), her “definitive turning 
point/downturn” was the day that she also identifies as her illness onset. She used 
the exact phrase “definitive turning point,” stating, “there is a definitive turning 
point August 22nd, 2006. After that, my life was never the same.” She elaborated 
further stating “after that one [illness episode] I did not recover. I never returned 
to work. Yeah, so everything changed from that point on.” 
 Tipping point. Two participants described the theme in terms of a tipping 
point. For example, Participant 12 (onset over 7-12 months) stated “whatever 
happened in March, I had an infection or whatever it was, just kind of tipped me 
over the edge.”  
 Participant 13 (onset over 1-2 years) describes a series of infections and a 
colonoscopy as the tipping point of her illness stating, “2006 was sort of when the 
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sinus infections and all those infections started. And then 2008 was when I had 
my colonoscopy and it just kind of pushed me over the edge.” 
Realization that something is wrong: Seven participants described a 
moment or period of time in which they understood that their illness was more 
than an ordinary sickness such as the flu, and there was something seriously 
wrong with them medically. A realization that something was wrong was 
described by individuals who endorsed a range of onset periods on the DSQ 
including: 24 hours (n=1), over 1 week (n=1), over one month (n=1), over 2-6 
months (n=2), over 7-12 months (n=1), and over 1-2 years (n=1).   
Participant 3 (onset over 24 hours) stated “I thought there was something 
seriously wrong with me and was sure that the blood tests would come up with 
some horrible news.” 
Participant 6 (onset over 1 month) stated, “the notion that there was 
something seriously wrong started creeping in.” 
Participant 1 (onset over 7-12 months) reported that she knew something 
was seriously wrong with her in the early stage of her illness stating, 
It was in the first two weeks actually. Week one, after a week of 
cold you think it would get better. You know what getting better 
feels like, and it just wasn’t happening. When I went into the 
second week, I was thinking, this is not normal, this is not normal. 
Steady progression. Six participants described their illness as a steady 
progression in which the illness and accompanying symptoms accumulated and 
worsened over time. A steady illness progression was described by individuals 
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who endorsed a range of onset periods on the DSQ including: over 1 week (n=2), 
over one month (n=2), over 2-6 months (n=1), and over 1-2 years (n=1).   
This theme is conveyed in a quote from Participant 6 (onset over 1 month) 
who described his illness progression in terms of a slow decline, stating “I had 
this initial hit and then there's just been this constant chipping away.” He also 
used the exact phrase “steady progression” stating, “from the initial illness it was 
this steady progression and I'd say it's been an accelerating one as of the last six or 
eight years have gone.” 
Participant 4 (onset over 1 week) stated, “I was getting progressively 
worse.”  
When referring to symptoms related to her illness Participant 14 (onset 
over 1 week) stated, “all these things were increasing over the following years.” 
Wax and wane/illness episodes. When describing the period of time in 
which initial symptoms developed, nine participants described their illness as 
something that waxed and waned. They often described this experience in terms 
of “phases” “cycles” and “illness episodes.” These illness periods were more or 
less severe at times during the development of the illness. A wax and wane/illness 
episode onset pattern was described by individuals who endorsed a range of onset 
periods on the DSQ including: 24 hours (n=1), over 1 week (n=2), over one 
month (n=1), over 2-6 months (n=2), over 7-12 months (n=1), and over 1-2 years 
(n=2).   
Participant 7 (onset over 2-6 months) provided a quote that specifically 
included the phrase “wax and wane.” 
 59	  
 It was kind of uh... wax and wane. Uh...again, it would maybe last 
a week or two...after the birth of my son. I...I didn't feel good for 
four months. And after the birth of my daughter it took about three 
months. 
Cycles. Two participants described this theme as “cycles” or “cyclical.” 
When describing her illness cycles, Participant 1 (onset over 7-12 months) stated, 
“they would last for hours and hours and hours, and day after day after day… 
[they] would come in cycles.”  
Participant 14 (onset over 1 week) described her illness cycles as variable 
in nature, stating, “eventually it went away and it would come back but it wasn't 
constant.” 
 Improvement. A sub-theme within the larger category of wax and 
wane was the specific description of periods in which illness improvement was 
noted. Six participants described periods of improvement with regard to their 
illness progression; however, this improvement was cyclical and always 
temporary. Periods of improvement may have been signified by either a brief or 
long period of symptom resolution, or a reduction in symptom severity. 
Participant 4 (onset over 1 week) stated, “I would start to get better and then by 
mid summer I would be feeling really pretty good. So the first year when this 
happened, I was...I thought you know, ok, you know I've gotten better.” 
Long-term improvement. Only one participant described a “slow” 
improvement of her illness over time; therefore, it is not considered a theme 
within the data, rather a category that separates this participant from the others. 
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  Participant 9 (onset over 24 hours) described how her illness has been 
slowly improving since 1986. 
Well you know I got somewhat better over the years. I mean, 
obviously, it's been since ’86, so there have been periods where 
I’m somewhat, but I’m certainly better than I was then, but um it's 
never you know gotten… really gotten better. 
Unnoticed progression. Two participants indicated that their illness 
progression was unnoticed at first and that it was only years later, and in hindsight 
that they realized that their illness had been developing for a long period of time.  
This theme was conveyed by Participant 6, (onset over 1 month), who now 
believes his illness started in his teen years. He reported that as a teen he did not 
have as much energy as other male peers his age; however, because of the large 
amount of energy that adolescent males have, he did not realize anything was 
wrong.  
 I was able to do everything else and that energy that I had lost  
  [from the illness], knocked off a piece of you know of the vast  
  amount [of energy] a 15 year old has, so it wasn't necessarily  
  noticed. It was, you know, as such… It's really only in   
  hindsight that I’ve realized, you know how significant it was at the  
  time and how it would, how it would progress. 
Participant 2 (onset over 1-2 years) described how she initially perceived 
her illness as part of the normal aging process. She stated: 
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 It took me ages to realize, because at that stage I said maybe this is  
  what getting old is about, because I'm 60 this year, you know, so at 
  57, I thought maybe this is the way life is just gonna be, you know  
  what I mean? 
Illness cause. Thirteen participants described their perceived cause of 
illness. Participant 12 (onset over 7-12 months) was the only participant who did 
not describe a perceived cause of illness. Subordinate themes within the larger 
theme of illness cause are listed below. It is important to note that many 
individuals reported that there was more than one possible cause of their illness, 
and therefore, they are included within more than one sub-theme. Three sub-
themes emerged from the larger theme of illness cause: 1. infectious/viral, 2. 
immune component, and 3. stress as a precursor. Other causes also emerged from 
the data but were not considered themes, as they were endorsed by one person. 
The additional illness causes described include the belief that the illness was 
caused by an adrenal problem, autonomic problems, diet, mosquito pesticides, 
mitochondrial disease, mold, and physical trauma.  
Infectious/viral. One sub-theme that emerged within the larger category of 
illness cause was the belief that the illness was caused by a virus or an infectious 
agent. Thirteen individuals reported that the cause or partial cause of their illness 
was viral or infectious in nature. 
When describing the onset period of her illness, Participant 4 (over 1 
week) stated “I had something that felt to me like a cold, or you know, a virus, it 
felt to me like a virus.”  
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Mono/Epstein-Barr virus (EBV). Six participants specifically believed that 
the development of mono and/or the Epstein-Barr virus (EBV) was the cause or 
the partial cause of their illness. For example, this sub-theme was conveyed by 
Participant 6 (over 1 month) who stated, “I got mono and never fully recovered.” 
Immune component. Five participants specifically described an immune 
component to their illness onset, development, and/or progression.  
Participant 11 (onset over 3 or more years) stated, “when you got mono on 
top of carrying Lyme, which is affecting the immune system, of course you're 
never going to get better.” 
Participant 13 (over 1-2 years) stated: 
 I do think that like uh... a series of illnesses, like stuff growing up 
sort of contributed and I just...I guess I just want to mention, I had 
um mono, which was in the mid 90’s. I had bronchitis in college 
and the late 90's, I was in a bad car accident in 2000… um, so I did 
have like a couple other significant things that I...I personally think 
weakened my [immune] system a little bit each time along the 
way. 
Stress as a precursor. While the majority of participants discussed 
stressful events leading up to or following their illness onset, two participants 
believed that stress played a significant role in the development of their illness. 
Participant 2 (onset over 1-2 years) stated, “so I think you know I keep looking 
for precursor things. I think that you've gotta add stress to the possible things.” 
 63	  
 When describing the cause of her illness development, Participant 5 (over 
1 month) stated, “it was probably overworking and the stress of moving.” 
Adapting and Coping. Nine participants described ways in which they 
coped and adapted to their illness onset. Adaptations and coping strategies in 
response to the illness were described by individuals who endorsed a range of 
onset periods on the DSQ including: 24 hours (n=1), over 1 week (n=2), over one 
month (n=1), over 2-6 months (n=2), over 7-12 months (n=1), over 1-2 years 
(n=1), and over 3 or more years (n=1).   
Behavioral coping. Within this larger theme, eight participants described 
behavioral forms of coping such as pacing, reducing work hours, reducing social 
activities, attending support groups, and creating symptom lists to keep track of 
the illness progression.  
Participant 2 (over 1-2 years) discussed the benefits of pacing stating: 
Two years in [to the illness] I attended a multidisciplinary chronic 
pain program which was eight hours a day for a month, and that 
was sort of enormously helpful in helping me come to terms with 
the fact that I couldn't do stuff, and in working out what my limits 
were and what I could do about it, and I think as a result of that 
program, I was able to sorta work more effectively, and I ended up 
getting tenure… and I think it's as clear as that. Without that 
program I think I probably would not have got tenure. 
 Participant 1 (over 7-12 months) discussed how she adapted by changing 
her daily routine to accommodate the illness. She stated, “I had to learn to 
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schedule to take a shower, and have at least two hours before getting up and doing 
something else. I needed to rest just to take a shower.” 
Change in mindset. Four participants discussed adapting to or coping 
with the illness by using internal and cognitive strategies, such as engaging in 
mindfulness/meditation, adopting a philosophical sense of acceptance of the 
illness, and optimistic thinking. 
 This theme is conveyed in a quote by Participant 2 (onset over 1-2 years) 
who discussed the benefits of mindfulness and meditation as forms of coping. She 
stated: 
Meditation, where you also watch your thoughts and try to be 
detached about them…and the very day I was diagnosed happened 
to be a day for that. I found that ability to be a bit detached just 
enormously helpful and it has continued to be a huge coping 
strategy. 
Participant 8 (onset over 3 or more years) discussed the value of 
acceptance of her illness stating, “I accepted it pretty 
philosophically. I didn't do a lot of chest beating.” 
Hardworking. Nine participants described themselves as hardworking or 
overworking in the year leading up to their illness onset and/or during the early 
development of their illness. Individuals who described working hard in the year 
leading up to their illness onset or during the early development of their illness 
endorsed a range of onset periods on the DSQ including: 24 hours (n=1), over 1 
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week (n=2), over one month (n=2), over 2-6 months (n=1), over 1-2 years (n=2), 
and over 3 or more years (n=1).   
Two participants specifically used the term “overworking.” For example, 
Participant 3 (onset over 24 hours) stated, “at the time I was a single mom with 
two teenagers and a mortgage. I worked full time. I loved my job um but I was 
indeed overworking for sure.” 
Participant 6 (onset over 1 month) discussed the price he paid for working 
too hard at the time that his illness was developing.  
I think that I worked longer than I should have, um for my health, 
for sure… um but I think I pushed myself you know a lot further 
than I think a lot of people might. Um which just kinda made my 
decline that much worse um you know and so I've had loss of 
function since then. 
Active prior to onset. All 14 participants described having active 
lifestyles prior to the onset of their illness. They described their engagement in 
sports, social activities, and work related activities.  
When describing the year prior to her illness onset, Participant 1 (onset 
over 7-12 months) stated, “it was great, I did yoga, belly dancing, meditation, you 
know all sorts of things. I was finishing my bachelors degree in psychology.” 
Participant 5 (onset over 1 month) described her many physical activities prior to 
her illness onset. She stated, “I was an avid hiker and climber and biker” 
Participant 7 (onset over 2-6 months) described her active lifestyle with fondness 
stating, “I was working as a nurse full time during those times, and felt pretty 
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good. And was active in helping my brother take care of their kids, and going on 
day trips and then dating um...and just enjoying life.” 
Healthy prior to onset. Nine participants considered themselves healthy 
prior to their illness onset. Many of these participants also identified health 
conditions or problems prior to their illness development; however, they still 
considered themselves as relatively healthy individuals. Individuals who 
described themselves as healthy prior to onset endorsed a range of onset periods 
on the DSQ including: 24 hours (n=2), over 1 week (n=1), over one month (n=2), 
over 7-12 months (n=1), over 1-2 years (n=1), and over 3 or more years (n=2).   
Participant 11 (onset over 3 or more years) discussed her health prior to 
onset stating, “I was in the best shape of my life.” 
Health problems prior to onset. While the majority of participants 
described themselves as relatively healthy prior to the onset of their illness, many 
of these same participants identified health problems and ailments in the months 
or year leading up to the onset of the illness. Eleven participants described one or 
more health problems leading up to their illness onset. Participants who described 
themselves as having health problems prior to onset endorsed a range of onset 
periods on the DSQ including: 24 hours (n=2), over 1 week (n=1), over one 
month (n=1), over 2-6 months (n=2), over 7-12 months (n=1), over 1-2 years 
(n=2), and over 3 or more years (n=2).  For example, Participant 1 (onset over 7-
12 months) described health symptoms she experienced in the months leading up 
to her illness. 
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I also noticed that kind of fatigue, and uh being much more tired 
than usual…. I noticed that. And then in the summer, July of 2006, 
July, August, I started noticing that when I stood for ten to fifteen 
minutes I would get out of breath and I would almost faint, I would 
have to sit down, it was so extreme I would break out into this 
sweat. I would feel extremely weak. I would need to sit down. That 
was very unusual but that definitely started happening around July, 
August. 
Frequent sicknesses. Five participants described experiencing frequent 
sicknesses, such as colds or persistent strep throat prior to their illness onset.  
Participant 7 (onset over 2-6 months) described a series of sicknesses 
while she was studying in nursing school and prior to the development of her 
illness.  
I recall that I was sick a lot in nursing school but it seemed to be 
more viruses because I had not been exposed, especially when I 
was in pediatrics. I was like sick all the time. I was hospitalized 
with pneumonia…um, but again, I thought I was just...that was just 
my resistance building up. I had several episodes of strep throat. 
 Participant 5 (onset over 1 month) also described frequent sicknesses in 
the year leading up to her illness onset.  
Prior to that I'd been having, maybe, well, I would say, everybody 
seems to…I'm not alone, I think in everybody saying that maybe 
the year or year or two prior in hindsight you seem to have a little 
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bit more um problems then you normally would, um you know, 
like flus or things that you didn't have before. 
Comorbid health conditions. Eleven participants reported that they had 
comorbid health conditions during their ME and CFS progression. Three 
subordinate themes emerged from the data: 1. fibromyalgia, 2. postural orthostatic 
tachycardia (POTS), and 3. irritable bowel syndrome (IBS). Additional 
comorbidities were reported; however they were not included as themes as only 
one participant endorsed having each condition. These comorbidities included 
migraines, temporomandibular disorders (TMD/TMJ), multiple chemical 
sensitivities, Lyme disease, thyroiditis, degenerative eye disease, ulcers, asthma, 
and deep vein thrombosis. Individuals who described comorbid health problems 
endorsed a range of onset periods on the DSQ including: 24 hours (n=1), over 1 
week (n=2), over one month (n=2), over 2-6 months (n=1), over 7-12 months 
(n=1), over 1-2 years (n=2), and over 3 or more years (n=2).   
Fibromyalgia. Six participants reported that they had a diagnosis of 
fibromyalgia in addition to ME/CFS.  
Participant 4 (onset over 1 week) discussed how when she was diagnosed 
with fibromyalgia she was not surprised, as she had wondered since she was a 
teenager if she had the condition.  
I also saw a rheumatologist who thought I had fibromyalgia and I 
kind of dismissed the diagnosis, because I thought I had 
fibromyalgia but I thought I had fibromyalgia you know, ever 
since I was a teenager…and I mean it wasn’t diagnosed then, but 
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when I first...when I first came...when I first learned what it was, 
which was several years prior to this time, I thought I probably had 
fibromyalgia, but I didn't think it was a big deal, but it didn’t stop 
me from doing anything. 
Postural orthostatic tachycardia. Three participants reported that they 
experienced Postural Orthostatic Tachycardia (POTS).  Participant 6 (onset over 1 
month) described how he was initially diagnosed with activity induced asthma 
when he was younger, but later realized he has been suffering from POTS all 
along. He sated, “the only diagnosis I got at the time was um activity induced 
asthma, and I think that, what was really going on was POTS, but nobody…POTS 
wasn't even in the lexicon in 1980. Nobody looked for that.” 
Irritable bowel syndrome. Two participants reported that they had irritable 
bowel syndrome (IBS). Participant 13 (onset over 1-2 years) described how she 
was diagnosed with multiple conditions including IBS stating, “I was diagnosed 
with IBS, TMJ, migraines, chronic fatigue syndrome, and fibromyalgia.” 
Emotional Response to Onset. Nine participants described their 
emotional response to their illness onset. A range of responses were noted, 
including fear, depression, confusion, and anger. Individuals who described an 
emotional response to onset endorsed a range of onset periods on the DSQ 
including: 24 hours (n=1), over 1 week (n=2), over one month (n=1), over 2-6 
months (n=2), over 1-2 years (n=1), and over 3 or more years (n=2).   
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Fear. Two participants described the feeling of fear in response to their 
illness onset. Participant 2 (onset over 1-2 years) described telling her family that 
she would never recover. She stated: 
 I'm calling up one of my sisters...my family is in Australia, so is 
my husband, and telling her about how scared I was that I wouldn't 
get well and I'd have to give up my job. I remember being just 
very, very freaked about the possibility that I had this disease that 
wouldn't go away. 
Depression/sadness. Four participants described experiencing periods of 
depression following the onset of their illness. Many participants described how 
the depression came once they came to the realization that the illness may never 
resolve.  
Participant 10 (onset over 2-6 months) described how the depression hit a 
year after her illness onset. She stated: Then after about a year, I'm starting to 
realize that this might not go away. This might take a while to go away. And I just 
started getting really depressed.” She elaborated further stating, “It was just like, 
this is insane, and you start to get really depressed. 
  She also described the belief that her depression was not wholly 
psychological. She suggested that the depression was partly a physiological 
response to her illness and partly due to environmental reasons such as 
invalidation from others.  
It really lingered. I mean it's been up and down for the past 25 
years of the depression, and I think part of it is physiological. I 
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think there is something about the illness that pushes people into 
the depression, and then I also think that it's environmental, you 
know. I think that when your life has been limited in such a way 
and your not being validated as someone who has an illness that's a 
very depressive situation. 
Confused. Two participants described the feeling of confusion in response 
to their illness onset.  Participant 11 (onset over 3 or more years) described 
feeling “perplexed” about how she could become sick in a matter of a day. She 
stated, “so a lot of it was denial, um, but you know just being totally perplexed by 
how you could go from totally healthy one day to being totally sick the next and 
not even know what happened.”  
Angry.  Two participants described feeling angry during their illness 
onset. Participant 10 (onset over 2-6 months) described anger about getting 
negative feedback from her doctors and their inability to tell her how to treat her 
illness. She stated, “I was getting angry! I was like don't tell me that I’m crazy, 
just tell me what I need to do.” 
No emotional impact. Two participants reported that their illness onset 
and early progression did not significantly impact them emotionally. Participant 
11 (onset over 3 or more years) stated, “Mentally, I was still emotionally there.”  
Exertional Effects. Eleven participants described how exertion, whether 
physical or mental, triggered or worsened their symptoms. Mild to severe exertion 
was described as causing a further decline in health. Individuals who described an 
exertional effects endorsed a range of onset periods on the DSQ including: 24 
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hours (n=1), over 1 week (n=2), over one month (n=2), over 2-6 months (n=1), 
over 7-12 months (n=2), over 1-2 years (n=2), and over 3 or more years (n=1).   
Participant 4 (onset over 1 week) described the difficulty of going to the 
grocery store. She stated, “It wouldn’t be uncommon for me to go to the grocery 
store and have to rest in the car for about 20 minutes before I would go in and 
doing grocery shopping.”  
Participant 6 (onset over 1 month) described the impact that mental 
exertion had on his illness. He described an instance in which he had severe 
exertional effects following the completion of a neuropsychological evaluation for 
his disability assessment. He stated: 
 I had to do an interview for disability, a neuropsych evaluation… 
an all day thing… um and I was in bed for three weeks. I was in 
horrible shape after that. I was essentially sitting at a desk for 8 
hours. 
Life Limiting. Twelve participants described how the illness limited their 
lives during their illness onset. They also discussed how the illness continues to 
limit their lives.  Participants described ways in which their family, social, and 
work lives were negatively affected by the illness. They also discussed a decline 
in their functional abilities. Individuals who described exertional effects endorsed 
a range of onset periods on the DSQ including: 24 hours (n=2), over 1 week 
(n=2), over one month (n=2), over 2-6 months (n=1), over 7-12 months (n=1), 
over 1-2 years (n=2), and over 3 or more years (n=2).   
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Participant 3 (onset over 24 hours) described the negative impact the 
illness had on her family and on her social life.  
I was pretty much unable to take care of my kids and work at the 
same time, so between coming home and just dropping at the 
door… um my kids were old enough to sorta help out, and uh they 
would sorta throw together some sorta of a dinner and we would 
have dinner together but I couldn’t really socialize. I was so dead 
by the end of the day, I was just like a plasma, and that went on 
again I guess until about October, so I was sleeping at every coffee 
break lunch break, I was going home and going straight to bed, um 
I wasn’t eating well, my kids weren’t eating well. 
 Participant 6 (over 1 month) specifically used the term “life limiting” and 
he described how he eventually became so limited that he could not drive and was 
mostly confined to his bed. He stated, “I got to the point where going to the doctor 
and then dropping off prescriptions off at a pharmacy was a limit, and I'm not 
driving basically… not driving at all right now, and you know mostly bed bound.” 
Stress. Twelve participants described experiencing stress in the year 
leading up and/or following their illness onset. Individuals who described 
stressful events or experiences endorsed a range of onset periods on the DSQ 
including: 24 hours (n=1), over 1 week (n=2), over one month (n=2), over 2-6 
months (n=2), over 7-12 months (n=2), over 1-2 years (n=2), and over 3 or more 
years (n=1).   
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Participant 5 (onset over 1 month) described multiple stressors leading up 
to her illness onset, including negotiating to buy a house with her husband, 
participating in a big art show, and the sudden death of her mother.  
When we first moved, since it was pretty stressful doing all the 
negotiating to get the house, stuff like that. It was at also at the 
same time, that we had our biggest art show of the year that we had 
to do, the resorts festival, so we were getting ready to do a 
seventeen day sting there at the same time that we were closing on 
our house, um so it was all that going on… I also had uh oh, oh, 
geez, I almost forgot, April my mother died suddenly um, how 
could I forget that…um we weren't terribly close but she was my 
mom, and we had a big family. 
 Participant 11 (onset over 3 or more years) described the stress she was 
experiencing concurrently with the onset of her illness. Specifically she discusses 
the stressors she experienced during her basic training to be an air force pilot.  
Unfortunately it happened on the second day of four weeks of 
basic training and I had no clue what had gone on other than you 
know it was a very stressful time. I was uh, I had to do very well at 
basic training because at the time, the pilot slots for women were 
very uh rare, and so you had to do very well on your application in 
order to get selected, and a lot of personal pressure on me, and then 
that first night, of course they overload on purpose because they 
are trying to make you quit and um, I stayed up all night, pulled an 
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all nighter essentially because your socks had to be exactly such 
and such length, and you know, all the certain way and all of that 
and they had you go to meetings and all this other stuff during the 
first day that you never had a chance to put this together. 
Traumatic experiences. Five individuals reported that they experienced 
trauma prior to the onset of their illness. The traumatic experiences that were 
discussed included a car accident, rape, falling down a staircase, severe childhood 
burns, and the traumatic delivery of one of their children. Three out of the five 
participants experienced the trauma as adults and closer in time to the onset of 
their illness. Individuals who described traumatic experiences endorsed the 
following onset periods on the DSQ: 24 hours (n=1), over 2-6 months (n=1), over 
7-12 months (n=1), over 1-2 years (n=1), and over 3 or more years (n=1).   
Participant 3 (onset over 24 hours) suggested that the physical trauma she 
experienced after falling down stairs had a role in her illness development.  
December 2002, I had a fall, um I fell down some stairs and was 
knocked out, so that was… you know, often you’ll hear about 
people who got fibromyalgia, they say that it can happen after 
some sort of traumatic event, physical event or emotional event, so 
I wonder if that played a part of it. 
 Participant 13 (onset over 1-2 years) described a car accident she 
experienced prior to her illness development.  
Yeah, so I um...I guess the most recent thing before all of the 
um...the...sinus infections and stuff was a car accident in 2000. 
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Where I was rear-ended and I got very bad whiplash, and it took a 
long time to get over that. I'm...my neck is still not the same. It still 
gets really tight. I developed scar tissue and stuff, so it was pretty 
significant for me. 
 This participant also suggested that the car accident along with a “series of 
illnesses” weakened her immune system.  
I had um mono, which was in the mid ‘90’s. I had bronchitis in 
college and the late ‘90's. I was in a bad car accident in 2000. Um, 
so I did have like a couple other significant things that I...I 
personally think weakened my system a little bit each time along 
the way. 
Lack of support. Seven participants described a lack of support following 
the onset of their illness. This included a lack of support from family, friends, and 
physicians. Individuals who described a lack of support following their illness 
onset endorsed a range of onset periods on the DSQ including: 24 hours (n=1), 
over 1 week (n=1), over one month (n=2), over 2-6 months (n=1), over 1-2 years 
(n=1), and over 3 or more years (n=1).   
Participant 10 (onset over 2-6 months) describes the lack of support she 
received from her family, friends, and her boyfriend during the onset of her 
illness. She stated: 
you’re alone, usually, right! You’re… you’re completely alone 
right? I did not have a support system. My parents are not 
supportive people. My boyfriend was not a supportive person! 
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(laughs) so I did not have support to encourage me… that… you 
know, maybe you can get over this. You know, maybe life will get 
better. That didn't happen, you know. I was alone most of the time. 
I was just trying to figure things out and then not getting a lot of 
help from the world. 
 Participant 5 (onset over 1 month) described the lack of support she 
received from doctors. She stated, “I kinda toughed it out on my own, because my 
past experiences with doctors, including the gastro I did see in December, kinda 
just blew me off.” 
 Support. Three participants described the support that they received 
during the onset and early progression of their illness. Individuals who described 
support following their illness onset endorsed the following onset periods on the 
DSQ including: over one month (n=1) and over 1-2 years (n=2).   
 Participant 2 (onset over 1-2 years) described the significant support that 
she received from her primary care physician during the period of time that she 
became ill.  
I consulted my own primary care physician who is someone who 
always believes me when I tell her how I'm feeling. She's great. 
She didn't blow me away which is I think the important thing. I 
think that I sort of totally proved myself as being a good dooby 
before I got sick because nobody thought I was faking and they 
have been incredibly understanding. 
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 Participant 6 (onset over 1 month) described the support he received from 
his general practitioner. He stated, “I guess I have to say, you know, as far as the 
way some people get treated by doctor's, I've been lucky. My GP has been very 
supportive. He also described the support he received from his wife stating, “my 
wife, you know cooks and cleans and takes care of the kids, and I do what I can 
for moral support essentially.” 
 Treatment limitations. Six participants described limitations of the 
treatments that they were receiving during the period of time when they became 
ill. Individuals who described treatment limitations endorsed a range of onset 
periods on the DSQ including: 24 hours (n=1), over 1 week (n=1), over one 
month (n=2), and over 1-2 years (n=2). 
 Participant 5 (onset over 1 month) described how her doctor told her that 
she could exercise, which only worsened her condition. She described how she 
learned later on that exercise could worsen her prognosis.  
Exercising and activity after the onset of illness to worsen your 
prognosis so… I read that too late (laughs) and my doctors told me 
that I had CFS which you are allowed to exercise… and if they had 
known about any of …they would have said hey, cut this out, lay 
down. 
 Participant 6 (onset over 1 month) described the antiviral treatment his 
doctor has tried. He stated, “she’s done you know antivirals and other things and 
we haven’t had any real luck. Basically getting treatment is either helping 
symptoms a little bit or it doesn’t help.”  
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Symptoms.  All fourteen participants identified symptoms that were 
experienced during the onset of their illness. Symptoms primarily fell in the 
following broad categories: flu-like symptoms, digestive symptoms, pain 
symptoms, autonomic symptoms, fatigue, post exertional malaise (PEM), sleep 
difficulties, and cognitive impairment. See Tables 5 and 6 for the full list of 
symptoms, including total frequency and percentage.   
Timeline Graphs 
 A total of 14 illness timeline graphs were constructed based on the 
participant interviews completed for the qualitative portion of the study. Seven 
participants (50 %) have provided corrections and feedback on their illness 
timelines and their graphs can be found in Appendix C. The illness timeline 
graphs provided a detailed chronology of each individual’s functioning over the 
course of their illness including the year(s) leading up to the onset and the initial 
month(s) and year(s) of onset. The illness timeline graphs reveal periods of severe 
disability, remission, and fluctuating illness patterns in a biographical context. 
The graphs are presented in Appendix C in order of the period of time in which 
individuals reported on the DSQ that their illness developed (24 hours, over 1 
week over 1 month, over 2-6 months, over 7-12 months, over 1-2 years, over 3 or 
more years). Areas shaded in green signify functioning levels above 50 and areas 
shaded in red signify functioning levels below 50.  
Participant Impressions 
 Feedback and impressions have been shared by eight out of the 14 
participants interviewed for phase two of the study. Overall, the feedback has 
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been positive and all participants have indicated that the themes and illness 
timeline graphs effectively summarize their experience. Five out of the eight 
participants provided minor corrections and additions to their illness graphs. 
Three reported that their graphs did not require any corrections/changes.  After 
reviewing the overall themes and key quotes that conveyed each theme, one 
participant commented, “I found that I could relate to the other participants as 
well. Each quote might as well have come from me too.”  Two participants 
elaborated on some themes. One participant who had described stress as a partial 
precursor for her illness development elaborated on this theme by describing how 
her stress was “good stress” that involved positive milestones in life (e.g. raising 
children and buying a house).  She stated “I was having the time of my life.”  
Another participant commented on the exertional effects theme and described 
how many individuals with the illness “realize too late the benefits of pacing.” 
She discussed how participants often realize the importance of reducing activities 
after the exertional effects have already taken a severe toll on the body. One 
participant noticed that she was initially categorized in the “onset over 3 or more 
years” onset group based on her answer to the onset question on the DSQ. 
However, she stated that her illness was sudden and developed over one day. This 
was reflected in her qualitative interview as well.  A few participants described an 
emotional reaction to reading the overall themes and from receiving their illness 
timeline graphs. One participant stated, “reading through my narrative made me 
very emotional. There is something about looking at your own words that makes 
it very validating. With that, comes an incredibly strong and direct connection to 
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the suffering I am having to minimize each and every day. It's like the floodgates 
open, and it's hard to contain all the emotions that are normally tucked away.”  
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Table 3 
Themes Pertaining to Onset/Progression, Illness Cause, Coping, Work, and 
Health (N=14) 
	  
	  
	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Themes Total 
    % (n) 
Onset/Illness Progression 100 (14) 
     Sudden    50 (7)  
     Exact Date   21 (3) 
     Definitive Turning Point   36 (5) 
     Realization that Something is Wrong   50 (7) 
     Steady Progression   43 (6)  
     Wax and Wane   64 (9) 
     Unnoticed Progression   14 (2) 
Illness Cause   93 (13) 
    Viral   93 (13) 
         Mono/EBV   43 (6)  
    Immune   36 (5) 
Stress   14 (2) 
Adapting and Coping   64 (9)  
Behavioral Coping   57 (8) 
Change in Mindset   29 (4)  
Hardworking   64 (9)  
Active Prior to Onset  100 (14) 
Healthy Prior to Onset    64 (9)  
Health Problems to Onset    79 (11) 
     Frequent Sicknesses    36 (5) 
Comorbid Health Conditions     71 (10) 
     Fibromyalgia    43 (6)  
     POTS    21 (3) 
     IBS    14 (2) 
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Table 4 
 
Themes Pertaining to Emotional Health, Exertion, Limitations, Stressors, and 
Treatment Limitations (N=14) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Themes Total 
 %  (n) 
Emotional Response to Onset 64 (9) 
     Fear 14 (2) 
     Depression 21 (3) 
     Confusion 14 (2) 
     Anger 14 (2) 
     No emotional response 14 (2) 
Exertional Effects 79 (11) 
Life Limiting 86 (12) 
Stress 86 (12) 
Traumatic Experience 36 (5) 
Lack of Support 50 (7) 
Support 21 (3) 
Treatment Limitations 43 (6) 
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Table 5  
Frequency of Flu-like, Gastrointestinal, Pain, and Autonomic Symptoms at Onset   
(N=14) 
 
 
  
Symptoms    Total 
     % (n) 
Flu-like     14 (2) 
Chills       7 (1) 
Sweating       7 (1) 
Sore throat       7 (1) 
Fever     29 (4) 
Headaches     36 (5) 
Coughing       7 (1) 
Vomiting       7 (1) 
Swollen Lymph Nodes/Glands     21 (3) 
Irritable Bowel Symptoms     14 (2) 
Nausea     14 (2) 
Diarrhea     21 (3) 
Pain     36 (5) 
Stomach Pain     21 (3) 
Muscle Pain     14 (2) 
Joint Pain     14 (2) 
Inflammation       7 (1) 
Cramping     14 (2) 
Heart Pain       7 (1) 
Autonomic        7 (1) 
Heart Rate Increase     14 (2) 
Irregular Heart Beat        7 (1) 
Low Blood Pressure       7 (1) 
Dizziness       7 (1) 
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Table 6 
 
Frequency of Fatigue, Sleep Difficulties, Cognitive Diffiuclties, Sensitivities, 
Endocrine, and Miscellaneous Symptoms at Onset (N=14) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Symptoms   Total 
   % (n) 
Fatigue    21 (3) 
Tired    21 (3) 
Exhaustion    57 (8) 
No Energy    21 (3) 
Post Exertional Malaiase    21 (3) 
Dead Weight      7 (1) 
Insomnia    21 (3) 
Lack Sleep    21 (3) 
Unrefreshing Sleep    14 (2) 
Nighttime Awakenings      7 (1) 
Increased Sleep    21 (3) 
Cognitive Difficulties    43 (6) 
Multitasking Difficulties      7 (1)  
 Brain fog      7 (1) 
 Difficutly Focusing      7 (1) 
Noise Sensitivity      7 (1) 
Light Sensitivity    21 (3) 
Weak feeling    14 (2) 
Eye Twitching      7 (1) 
Difficulty Swallowing      7 (1) 
Weight loss      7 (1) 
Numbness    14 (2) 
Temperature Intolerance    14 (2) 
Tingling       7 (1) 
Malaise      7 (1) 
Breathing Difficulty      7 (1) 
Visual Difficulty      7 (1) 
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Discussion 
 The current study serves as an investigation of onset patterns associated 
with ME and CFS. Overall, results of the quantitative portion of the study (phase 
one) revealed that mode of illness onset (sudden versus gradual) did not 
differentiate individuals on key factors related to etiology, psychopathology, and 
prognosis. The qualitative portion of the study (phase two) provided rich 
descriptions of onset experiences across participants who endorsed a range of 
onset timeframes on the DePaul Symptom Questionnaire (DSQ; from 24 hours to 
over 3 years). These rich descriptions provide insight into the symptoms, onset 
patterns, and early characteristics associated with the initial phase of the illness.  
Quantitative/Phase One: Major Findings and Implications 
 Results of hypothesis I revealed that that the proportion of participants 
who reported that an infection preceded illness onset did not significantly differ 
by mode of illness onset (sudden versus gradual). In the current study, more than 
half of participants in both onset groups endorsed an infectious cause of illness on 
the Depaul Symptom Questionnaire (DSQ; Jason et al., 2010). Previous research 
has suggested that a sudden/acute onset of CFS is associated with a 
viral/infectious etiology (Komaroff, 1988, 1994; Hay & Jenkins, 1994). The 
findings from the current study suggest that participants perceive the cause of 
their illness as infectious/viral regardless of onset type.  
 Results of hypothesis II revealed that the percentage of participants who 
reported the cause of their illness as “Definitely Physical” or “Mainly Physical” 
did not differ across individuals with a sudden versus gradual onset.  Previous 
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studies have found that participants with CFS are significantly more likely to 
report that their illness developed from physical causes rather than psychological 
causes (Butler, J. A., Chalder, T., & Wessely, S., 2001; Clements, A., Sharpe, M., 
Simkin, S., Borrill, J., & Hawton, K., 1997; Powell, R., Dolan, R., & Wessely, S., 
1990). To this author’s knowledge, no previous studies have investigated whether 
participants’ attributions (physical versus psychological) of the cause of ME and 
CFS is differentiated by mode of illness onset. Results of the current study were 
insignificant, revealing that illness attribution was not differentiated by mode of 
onset. This finding is consistent with the qualitative phase of the current study 
(presented below) showing that nearly all participants (93%) regardless of onset 
group attributed the cause or partial cause of their illness to an infection or virus.  
 Results of hypothesis III revealed that there was not a clinically significant 
main effect of onset group on mental health functioning; however, a trend was 
noted in the expected direction, with participants in the sudden onset group 
reporting higher mental health functioning than individuals in the gradual onset 
group. Furthermore, results of hypothesis IV revealed that the percentage of 
participants who endorsed at least one lifetime psychiatric diagnosis did not differ 
by onset group. Overall, these results suggest that mode of illness onset did not 
differentiate individuals on factors related to psychopathology. Findings within 
the ME and CFS literature are mixed with regard to whether illness onset can 
differentiate individuals based on psychological factors. Consistent with the 
current findings, Cukor, Tiersky, and Natelson (2000) did not find evidence that 
sudden versus gradual onset groups can be differentiated based on 
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psychopathology.  Jason et al. (2000) and Reyes et al. (1999) found that 
individuals with a sudden onset of CFS from community-based samples 
evidenced higher rates of psychiatric comorbidity; whereas, DeLuca et al. (1997) 
found that those with a gradual onset evidenced higher rates of psychiatric 
comorbidity. Furthermore, Salit (1997) found fewer rates of depression in 
individuals with a sudden/acute onset.  
 Results of hypothesis V revealed that there was not a significant effect of 
onset group on overall physical functioning. Findings are mixed within the CFS 
literature regarding the extent to which illness onset is predictive of health 
outcomes. Jason et al. (2000) and Njoke, Jason, Porter, and Brown (2009) found 
that sudden illness onset was associated with poorer outcomes compared to those 
with a gradual onset. However, Reyes et al. (1999) and Hill et al. (1999) found 
that mode of illness onset was not predictive of health outcomes.  
 Overall, results of the quantitative findings, suggest that mode of illness 
onset as it has been defined in the literature (sudden versus gradual) and in the 
current study, may not significantly differentiate individuals on factors related to 
illness cause, psychopathology, and health outcomes in individuals with ME and 
CFS.   Interestingly, a recent study by Jason, Evans, Brown, Sunnquist, and 
Newton (2015) found that participants who met criteria for ME with an acute 
onset (onset over 24 hours to 1 week) had greater physical function impairment as 
well as physical, mental, and cognitive problems than individuals who met CFS 
criteria. These findings suggest that the combination of mode of illness onset and 
case criteria may be important for identifying subtypes of the illness.  
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Qualitative/Phase Two: Major Findings and Implications 
 The qualitative interviews in the current study yielded rich descriptions 
that provide insight into the way people with ME and CFS describe their illness 
onset, including perceptions of mode of onset, illness progression, functional, 
social, and treatment limitations, emotional responses, degree of support from 
others, and early health problems and symptoms.  Within the category of 
onset/illness progression, 50% of participants endorsed a sudden onset of ME 
and/or CFS. These findings are consistent with the qualitative study by Ray et al. 
(1998), which revealed that 50% of a sample of CFS participants reported a 
sudden illness onset.  Another onset theme that emerged within the current study 
was the experience of a steady progression of symptoms that accumulated over 
time (endorsed by 43% of participants). This theme is also consistent with Ray et 
al. (1998) who found that 25% of their study population described a gradual 
illness onset in which people reported a slow, worsening of symptoms over time. 
A third theme that emerged within the onset/illness progression category of the 
current study was the experience of a wax and wane progression in which there 
were periods of improvement/remission and periods of worsening symptoms 
accompanied by a noticeable decline in functioning. This wax and wane pattern 
was described by 64% of participants, who used terms such as illness episodes, 
phases, and cycles.  This theme is similar to the two-phase illness onset group 
previously described by Ray et al. (1998). Ray et al. (1998) describes this phased 
onset as a sharp deterioration of health followed by improvement in phase one, 
which is then followed by another deterioration of symptoms in phase two. Ray et 
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al. found this pattern in 23% of their sample. The wax and wane pattern found in 
the current study differs from the two-phase theme described by Ray et al. (1998), 
in that it is not limited to “two phases.” Many participants in the current study 
described numerous illness phases throughout the course of their illness 
progression.  Another way in which the onset themes of the current study differ 
from Ray and colleagues (1998) is that they are not mutually exclusive. 
Specifically, some participants endorsed a sudden onset followed by a steady 
progression of the illness. Other participants described a sudden onset and a wax 
and wane illness course rather than a steady progression of symptoms.  
 Additional onset/illness progression themes emerged from the data. A 
subset (21%) of participants reported the exact date of illness onset. As might be 
expected, all of these individuals described their onset as sudden. DeLuca et al. 
(1998) suggested that a specific date is necessary in order to categorize someone 
as having a sudden CFS onset. However, the qualitative findings of the current 
study reveal that the majority of individuals who endorsed a sudden illness onset 
did not name the exact date of onset. This finding suggests that requiring a 
specific date of onset could be too strict for determining mode of illness onset.  
 A subset (14%) of participants described the experience of an unnoticed 
illness progression. These individuals also described a steady progression of their 
illness in which symptoms and functional limitations slowly increased over time. 
Previous qualitative studies have not specifically identified or described this 
experience of an unnoticed illness progression.  These findings have clinical 
implications, as individuals who do not recognize the progression of their illness 
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until years later likely will not seek medical care and support as quickly as others 
who identify that something is wrong earlier in the illness development. This 
could ultimately impact the course, treatment, and prognosis of the illness. 
 Thirty six percent of participants also described a definitive turning 
point/downturn in their illness progression in which symptoms and functional 
limitations significantly worsened. Furthermore, 50% described a moment in the 
illness progression in which they realized that something was seriously and 
medically wrong with them.  These experiences were significant for participants 
as they signified a period of the illness development in which there was gained 
insight on the seriousness of the illness. These experiences could have clinical 
significance for patients, as they potentially mark a point in time in which they 
feel the need to seek medical treatment and make steps to receive a diagnosis.  
 The majority of participants (93%) from the qualitative sample reported 
that a virus or infection was the cause of or partial cause of the ME or CFS onset. 
This finding is consistent with the quantitative findings in phase one that are 
presented above. The majority of participants from the larger quantitative sample 
reported on the DSQ that an infection or virus preceded the illness onset. 
Furthermore, mode of illness onset did not differentiate individuals based on 
viral/infectious etiology.  These results are also consistent with Ray et al. (1998) 
who found that a subset of all three onset groups identified in their study (sudden, 
gradual, and phased) endorsed a viral/infectious onset.  
   Ray et al. (1998) found that a portion of participants attributed their illness 
development to their immune system “breaking down.” A subset (36%) of 
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participants in the current study also endorsed an immune component to their 
illness cause. These individuals typically described a series of infections (one 
individual described infections in combination with a physical trauma) that 
negatively impacted the immune system over time. These findings are consistent 
with an immune component theory posed by Hyde et al. (2007) who asserts that 
ME often follows multiple, minor infections in individuals with susceptible 
immune systems or immune systems that are weakened by severe stressors (e.g. 
contact with infectious persons, exhaustion, trauma, immunizations, epidemic 
disease, travel and exposure to virulent agents). Additionally, prior research has 
evidenced immune dysfunction and damage to the CNS in individuals with CFS 
(Broderick et al., 2010).  
 Ray et al. (1998) found that individuals with a sudden or “sharp” onset 
were most likely to report that an infection was a trigger for illness onset. 
Additionally, Ray reported that individuals with a sudden onset more often 
describe pre-onset factors (e.g. stress, overactivity, predispositions for health 
problems etc.) that may have built up and contributed to the onset of illness. 
Additionally, Ray found that individuals in the phased group were more likely to 
describe exacerbating illness factors that followed the onset of their illness. In 
contrast, the current study showed that the majority of participants identified an 
infection or virus as the trigger for their illness regardless of onset type. 
Furthermore, pre-onset triggers and post-onset exacerbating factors (e.g. 
overexertion) were endorsed regardless of onset type.  
 93	  
 A small subset of participants (14%) reported that stress was a partial 
cause of their illness onset.  Ray et al. (1998) found that some individuals in their 
sample described what Ray and colleagues referred to as “complex” onset 
contributory factors, which included a combination of infection, overexertion, and 
stress. A qualitative study of illness beliefs in individuals with CFS revealed that 
56% of participants believed that stress/lifestyle contributed to the onset of CFS; 
however, similar to the current study, none believed that stress was the sole cause 
of illness onset (Clements et al. 1997). Salit found that individuals with CFS 
(regardless of onset group) reported a higher number of stressful life events prior 
to CFS onset compared to a control group (1997). In contrast MacDonald et al., 
(1996) did not find an increase in life stress in the year before the onset of CFS.  
 Thirty six percent of participants described traumatic events over the 
course of their lives. Only one participant suggested that the cause of the illness 
was partially due to the trauma.  Overall, the current study revealed that the 
majority of participants (86%) endorsed stressors in the year leading up to and 
following illness onset; however, the stress was not described as a precursor to the 
development of the illness, but rather something that exacerbated the illness.   
 Many participants in the current study described the experience of 
working hard, and a small subset within this theme discussed the experience of 
“overworking” in the year leading up to their illness onset. In an anthropological 
study of the experience of CFS, Ware (1993) writes about individuals’ 
descriptions of working hard in the year or years leading up to their illness onset. 
Ware described this hardworking behavior in terms of “type A” and 
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“perfectionistic” characteristics that led many to feel exhausted. While some 
participants in the current study indicated stress or exhaustion in the year leading 
up to their illness, the majority described their hardworking styles in a positive 
manner. Furthermore, this hard work ethic was often described in order to show 
the stark contrast to their considerably more limited lives (functionally and 
socially) following illness onset. In fact, all 14 participants in the current study 
described having active lifestyles including a range of both work and recreational 
activities. The findings from the current study suggest that when assessing for 
factors related to stress and functioning leading up to the onset of ME and CFS, it 
would be beneficial to include questions that assess for whether these activities 
were deemed stressful or taxing, as this may have implications for illness 
attributions and whether stressful experiences and lifestyles are truly perceived as 
contributory to onset.   
 A majority (79%) of participants in the current study reported that they 
were relatively healthy prior to the onset of their illness. This finding is consistent 
with a qualitative study by Lovell (1999), which found that aid workers who 
developed CFS when living overseas considered themselves as healthy before the 
development of the illness. While the majority of participants in the current study 
considered themselves relatively healthy prior to onset, 79% also described 
notable health problems in the year or years leading up to the onset of the illness. 
Within this category, 36% described the experience of being frequently sick with 
colds or sore throats.  A previous study conducted by this author and colleagues 
found that individuals retrospectively reported experiencing multiple health 
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symptoms prior to the onset of their fatiguing illness. These included Fukuda et 
al. (1994) symptoms, neurological impairments, sensitivities, cardiovascular 
symptoms, loss of thermostatic stability, pain, sleep disturbances, neurosensory, 
perceptual, and motor symptoms, neuroendocrine, and mood symptoms (Evans, 
Barry, Brown, & Jason, 2015). The presence of health problems and symptoms 
prior to the onset of the illness could potentially be identified as risk factors for 
ME and CFS. These health problems may also influence illness course and 
differentiate individuals with ME and CFS into subtypes (Evans et al., 2015).  
Participants identified symptoms experienced during the onset of their 
illness. Specifically participants described symptoms that generally fell in the 
following categories: flu-like symptoms, digestive problems, pain, autonomic 
dysfunction, fatigue, post exertional malaise (PEM), sleep difficulties, and 
cognitive impairment. Two symptoms that were endorsed with the highest 
frequency were “exhaustion” (57%) and general cognitive difficulties (43%). In 
congruence with the tenets of qualitative description, the author made an effort to 
use words to describe symptoms that were also used by the participants 
themselves. It is notable that a large proportion of participants used the term 
“exhaustion” rather than only fatigue. Future surveys designed to assess early 
signs and symptoms within the onset period should consider using the 
participant’s preferred language for their symptoms. Overall, the identification of 
early signs and symptoms of the illness could be beneficial for early intervention 
and treatment.   
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 Many participants described comorbid health conditions including 
fibromyalgia, POTS, and IBS. These findings are consistent with previous 
quantitative studies that have revealed that CFS is highly comorbid with 
fibromyalgia (Buchwald & Garrity, 1994), IBS (Whitehead, Palsson, & Jones, 
2002), and POTS (Steward, Gewitz, Weldon, Arlievsky, & Munoz, 1999). 
Individuals with highly comorbid conditions may be at risk for developing ME 
and CFS, and they may also negatively influence the severity of onset and illness 
trajectory.   
 A majority (79%) of participants described the negative impact that 
exertion had on their symptoms and illness course. These exertional effects 
included both mental and physical exertion. Post exertional malaise (PEM) has 
been found to elicit a worsening of symptoms (e.g. fatigue, headaches, cognitive 
dysfunction etc.) following routine daily tasks including going to the grocery 
store, walking, and showering (Spotila, 2010).  Jason et al. (1999) found up to 
93.8% of individuals with CFS endorsed the experience of PEM depending on 
how the questions on a survey were worded. Furthermore, PEM has also been 
measured using objective methods (Light, White, Hughen, & Light, 2009). 
 Participants described both behavioral and mental/internal forms of coping 
in response to the onset of ME and CFS. Behavioral forms of coping included 
attempts to limit activities to prevent overexertion, attending support groups, and 
creating symptoms lists. In an earlier qualitative study on illness perceptions in 
individuals with CFS, Clements et al. (1997) also found that individuals described 
behavioral forms of coping such as pacing and reducing activities. Findings from 
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the current study as well as by Clements et al. (1997) also revealed that these 
strategies were considered most helpful to symptom management rather than as a 
cure for the illness. The pacing strategy endorsed by many individuals in the 
current study has been supported by the energy envelope therapy, which suggests 
that balancing perceived energy with expended energy can help individuals with 
ME and CFS conserve energy and reduce overexertion (Jason et al. 1999; Jason et 
al. 2010; Pesek, Jason, & Taylor, 2000). Other forms of coping described in the 
current study involved internal methods, such as a changing one’s mindset.  For 
example, many individuals described the development of a philosophical 
acceptance of the illness. This experience of gaining acceptance is consistent with 
Fennell’s phase theory of CFS (1995) in which participants reach acceptance of 
the illness in phase three following the crisis and stabilization experiences in 
phase one and two. While the experience of acceptance was described by 
individuals following the initial crisis phase in the current study, some 
participants found acceptance relatively early on in their illness progression and 
even before reaching “stabilization.”    
 Qualitative findings from the current study suggest that the onset of illness 
had an emotional impact on more than 50% of participants. Some participants 
described going through periods of depression, whereas others described fear, 
anger and a state of confusion regarding the onset of the illness.  This is consistent 
with findings from a mixed method study by Tuck and Wallace (2000) who found 
that compared to a control group, women with CFS reported significantly higher 
levels of depression, anxiety, anger, and confusion following the onset of their 
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illness. The experience of depression following onset was corroborated in 
qualitative interviews (Tuck & Wallace, 2000). These findings suggest that the 
onset of ME and CFS can have a profound emotional impact on the sufferer.  
Individuals with ME and CFS could benefit from significant emotional and 
instrumental support from friends, family, and health providers during the earliest 
phase of illness development.  
 A large majority of participants described many ways in which the illness 
limited their lives in terms of work, social life and family responsibilities. 
Consistent with this finding, Schweitzer (1995) and Anderson and Ferrans (1997) 
found that individuals with CFS report significantly impaired quality of life.  
Furthermore, while a small subset of individuals described the support they 
received during the onset of ME and CFS (21%), half of participants described the 
lack of support they received from others (friends, family, and doctors) during the 
onset of the illness. A qualitative study by Dickson and Flowers (2007) found that 
CFS participants described a sense of loneliness, isolation, and lack of support 
from friends, family, and general practitioners. A needs assessment by Drachler et 
al. (2009) revealed that individuals with ME and CFS expressed the need for 
support in understanding and receiving a diagnosis, validation from health 
providers and family, as well as support in finding ways to engage in social 
activities. A mixed method study by Schoofs, Bambini, Ronning, Bielak, and 
Woehl (2004) found that individuals with CFS lack social support and their 
degree of perceived social support was correlated with quality of life factors. 
Jason, Witter, and Torres-Harding (2003) have provided evidence that perceived 
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social support is correlated with physical health outcomes in individuals with 
CFS.  These previous findings in conjunction with the current findings suggest 
that individuals with ME and CFS are severely lacking a sense of support from 
others (health providers and family/friends) during the onset of illness and in the 
years following onset.  
 In addition to the limited perceived support, 43% also described 
limitations of the many treatments that they tried during the early development of 
their illness. Currently there is not a gold standard treatment for the illness due to 
the multidimensionality of the illness, the absence of a confirmed etiology, and 
the variability in case criteria for diagnosing the illness (Afari & Buchwald, 
2014). A lack of social support and an absence of effective treatments available in 
the early stages of the illness likely has a negative impact on the course of illness 
and overall quality of life in individuals with this debilitating illness.   
 Overall, the qualitative findings provide insight into how individuals with 
ME and CFS describe and reconstruct their illness onset and progression. 
Findings of the current study revealed many commonalities with by Ray et al. 
(1998). Most notably, both studies reveal that ME and CFS onset is likely more 
complex than the dichotomous categorization of onset (sudden versus gradual) 
that is commonly described in the literature. Both studies found evidence for the 
experience of sudden, steadily progressing/gradual, and phased onset patterns. 
However, the current study findings differ from Ray et al. (1998), as participants 
in the current study were often included in more than one onset group. For 
example, an individual with a sudden onset could experience a steady progression 
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or a wax and wane illness pattern. These findings suggest that onset and illness 
progression may be even more complex and dynamic than Ray and colleagues 
(1998) have suggested. Furthermore, the current study findings suggest that onset 
and illness progression are closely tied together and constructs that are not easily 
differentiated (e.g. steady progression may describe an illness course as well as a 
gradual onset). Additionally, the current study found evidence of a “definitive 
turning point/downturn” in the ME and CFS illness progression, as well as a 
moment when participants realized that something was seriously wrong 
medically. These themes have significant clinical and research implications, as 
they denote a period in time in which an individual might pursue medical care and 
also begin the search for a diagnosis. A better understanding of the signs and 
symptoms that accompany these moments of insight might lead to interventions 
that focus on earlier points in the illness trajectory and for individuals who might 
have otherwise recognized the severity of their illness much later.  
Timeline Graphs and Implications 
 Illness timeline graphs were created for all 14 participants from phase two 
of the current study. Eight participants provided feedback and corrections on their 
illness graphs and these are shown in Appendix C. The timeline graphs provide a 
visual display of functioning and disability over the ME and CFS illness trajectory 
(the period leading up to illness onset, at onset, and following onset).  The graphs 
provide insight into periods of improvement and decline over the course of the 
ME and CFS illness, in the context of various life events, health experiences, and 
interventions/treatments.  
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 The ME and CFS illness timeline graphs of the current study fit nicely 
within the trajectory framework of chronic illness by Corbin and Strauss (1991).  
Corbin and Strauss (1991) describe a trajectory as an illness course that is shaped 
by the ill individual, his/her family members, friends, and health care providers, 
over time.  Different illness phases are described by Corbin and Strauss (1991) 
and they include the biographical and health events that are present before the 
onset of illness (pre-trajectory), the period of time in which symptoms and signs 
first appear (trajectory onset), life threatening emergencies (crisis phases), 
“active” illness periods that may require hospitalization (acute phases), periods in 
which the illness is relatively well managed (stable phases), periods of fluctuating 
illness that are poorly controlled (unstable phases), periods of illness 
progression/decline (downward phases), and lastly, the final phase of life (dying). 
These phases (with the exception of the dying phase) are made visible by the 
illness timeline graphs of the current study.  
 Corbin and Strauss (1991) discuss implications for thinking about chronic 
illness in terms of a trajectory. Specifically, an understanding of illness course can 
help one better manage disability and improve quality of life, help change or 
shape the course of illness, and more effectively manage symptoms. Furthermore, 
while health care providers may have an understanding of a patient’s medical 
course and treatment history, an illness trajectory can provide additional insight 
into the way in which individuals manage and shape their illness in the context of 
daily life (Corbin and Strauss, 1991). They point out that many of the strategies 
that are used to manage illness occur at home and not in medical offices or 
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hospitals.  Furthermore, they discuss how a trajectory can reveal how pre-illness 
and pre-medial intervention experiences shape the way individuals understand 
and respond to their illness and to their health care providers (Strauss & Corbin, 
1991).   
 Illness timeline graphs have many clinical and research implications 
within the ME and CFS context. Specifically, they allow for years of illness 
information to be displayed in a more digestible, visual format. Furthermore, the 
timeline graphs can be used by patients to track symptoms over time and to 
identify potential factors that contribute to periods of illness remission or decline. 
An individual with ME and CFS may identify a period in his/her illness course 
when a certain medication or behavioral coping strategy (e.g. pacing) was 
associated with an improvement in functioning and quality of life. Henly, 
Wyman, and Findorff (2011) have also described how the process of tracking 
illness trajectories can highlight factors that contribute to illness changes and can 
allow patients to potentially take control over their illness course. In the current 
study, one participant, who described herself as a “highly visual person,” reported 
that the opportunity to see the peaks and valleys of her functioning over time 
provided her with heightened clarity about her illness experience.  
 The process of visually tracking ME and CFS illness progression may help 
to identify different subtypes of the illness, which then may help health care 
providers tailor treatments to the individual. A person who has had a slow and 
downward progression of their ME or CFS would likely benefit from different 
treatments/recommendations than an individual who has demonstrated a wax and 
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wane and unpredictable illness course. Additional research on pre-trajectory, 
trajectory onset, and illness course patterns may also lead to the identification of 
early signs/symptoms and methods that focus on early intervention/prevention of 
the illness.  
 Visual illness timelines have been used previously in health research. A 
study by Lunney, Lynn, Foley, Lipson and Guralnik (2003) utilized graphical 
timelines to show that end of life functioning was highly variable across four 
different types of end of life trajectories (e.g. sudden death, cancer death, death 
from organ failure, and frailty). The authors suggested that the health trajectories 
can be used to tailor end of life interventions to the individual in order to improve 
overall quality of life. Another study by Bausewein and colleagues (2010) used 
graphical timelines to show the trajectory of breathlessness in individuals with 
chronic obstructive pulmonary disease (COPD). Their findings showed that those 
who have worsening or fluctuating breathlessness trajectories may have a more 
difficult time predicting and controlling the symptom and likely require 
individualized treatment. Similar methods could be used for understanding illness 
patterns in individuals with ME and CFS.  
 Further still, illness graphs can be used as communication tools for 
patients who are meeting with new health care providers and who might not have 
a full understanding of a patient’s illness history and course. Patients can use the 
graphs to provide their health care providers with a sense of how their symptoms 
have changed over time, the various treatments that they have tried, and whether 
the illness is worsening. Cognitive difficulties including word finding and brain 
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fog difficulties are cardinal symptoms of ME and CFS. Many participants in the 
current study discussed how these problems make it extremely difficult to have a 
conversation. Therefore, a visual graph of their illness trajectory may be easier to 
share with a health provider than providing a verbal account of their illness 
history.   Additionally, The sharing and co-construction of an illness history 
between patient and health care provider may increase the degree of support and 
validation that patients receive at their medical visits.  Kleinman (1988) refers to a 
patient care model called  “empathic witnessing” in which there is an “existential 
commitment to be with the sick person and to facilitate his or her building of an 
illness narrative that will make sense of and give value to the experience” (p. 54). 
This act of witnessing and sharing an illness narrative has been described as a co-
construction between patient and physician (Verghese, 2001) and is theorized as a 
way to promote validation and empathic interactions between patients and health 
care providers. Corbin and Strauss (1991) discuss how pain patients who present 
to a health clinic are often coming with years of health experiences that influence 
how they react to treatment and to their providers. Specifically, they discuss how 
a patient who is branded as “difficult” by a health care provider is likely reacting 
to past experiences and interactions with previous providers (Fagerhaugh and 
Strauss 1977 as cited in Corbin & Strauss, 1991). Knowledge of a person’s illness 
history and previous interactions within the healthcare system can help providers 
shape the attributions they make about patients and it can lead to increased 
empathy and support.  Given the lack of support that many participants in the 
current study experienced from health providers, friends, and family members, the 
 105	  
illness timelines may provide a way for health care providers to better connect 
with their patients on an empathic level. 
Limitations 
 The samples in phase one and phase two of the current study were not 
selected through random assignment; thus, participants in the current convenience 
sample may have different qualities than a more representative population of 
individuals affected by ME and CFS. For instance, in both phase one and two, 
participants were largely White women and middle aged. Based on research by 
Jason and colleagues (1999), CFS occurs at higher rates in African-American and 
Latino samples. Another limitation of the current study is the retrospective nature 
of the self-report method and qualitative interviews. Participants provided self-
reported information on their illness onset, which in many cases occurred many 
years prior. It is possible that their responses are biased due to recall difficulties 
that occur when remembering remote events. While the potential for recall bias is 
a limitation of the current study, highly salient information is often recalled more 
accurately than less salient information (Cannell, Marquis, & Laurent, 1977; 
Dawson, Kanim, & Sra, 2002; Stull et al., 2009). The majority of individuals in 
the current study described their onset period as a “life changing” and a salient 
period in their life.    
 There is significant variability in the ME and CFS literature with regard to 
the way in which sudden versus gradual onset is defined. Furthermore, differences 
across samples (e.g., community based versus tertiary) and across case definitions 
used to select for ME and CFS increases the difficulty in comparing the results of 
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the current study with previous findings. The current study defined sudden onset 
as occurring between 24 hours to one month, and gradual as any onset greater 
than one month. This decision was based on previous research, in which sudden 
onset was defined as up to one month (Jason et al., 2000).  Unfortunately there is 
not yet a uniform definition for mode of illness onset, thus contributing to the 
wide variety of onset definitions in the literature. For example, Salit (1997) 
defined sudden as occurring in conjunction with an “acute precipitating event,” 
whereas gradual onset was defined as any onset that did not have an “acute 
precipitating event” (p. 61). Similarly DeLuca et al. (1997) described sudden 
onset as viral with a clear onset date and gradual onset was defined as slowly 
progressing over “weeks to several months or greater” (p. 85). Overall, 
differences in methodology, onset categorization, diagnostic criteria, and sample 
selection across studies make the comparability of onset differentiation on key 
factors of ME and CFS a complicated endeavor.   
Conclusions and Future Directions 
 Overall, results of the current study did not provide evidence that mode of 
illness onset (defined as sudden versus gradual) differentiated patients on factors 
related to etiology, psychopathology, and prognosis. However, qualitative 
findings and illness timeline graphs revealed that ME and CFS onset experiences 
are likely more complex than the dichotomous sudden versus gradual 
categorization that is ubiquitous in the ME and CFS literature. The findings of the 
current study are aligned with recommendations for future research that were 
suggested by Ray et al. (1998). Ray et al. (1998) recommended that future studies 
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should involve the investigation of different etiological onset patterns as well as 
the potential interactions between various causal factors (e.g. infection, stress, and 
overexertion) and the degree of risk that these pose for the future development of 
the illness. In addition to these recommendations, the current study findings 
suggest that onset and illness progression may be even more dynamic and 
complex than is described by Ray et al. (1998). Specifically, the onset patterns 
revealed in the current study do not appear to be mutually exclusive (e.g. patients 
may identify with both sudden and steadily progressing/gradual onsets).  These 
findings point to the need for further assessment of illness onset patterns and 
progression on larger and more representative populations. Furthermore, it is 
recommended that surveys designed to assess the onset experience include more 
than one question to assess mode of illness onset and illness patterns. In order to 
capture the complex ME and CFS onset experiences, surveys might include 
questions that assess the period of time in which an individual’s first symptoms 
were experienced, whether the individual perceived their onset as sudden 
(regardless of the period of time that their first symptoms developed), whether the 
illness progression was initially noticed, and whether it progressed in the form of 
a steady progression or a cyclical “wax and wane” pattern. Furthermore, it would 
be beneficial to ask individuals about how long it took in days, months, and/or 
years until they experienced a “definitive turning point” in which functioning 
significantly decreased, as well as when they experienced a period of reflection in 
which the illness was perceived as something more serious than a typical sickness 
such as the flu (See Appendix D for a sample onset questionnaire).  
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 A recent study found that participants who met criteria for ME with an 
acute onset had greater physical function impairment as well as physical, mental, 
and cognitive problems than individuals who met CFS criteria. These findings 
suggest that the combination of mode of illness onset and case criteria may be 
important for identifying subtypes of the illness. More research on the interaction 
between case criteria and onset patterns and the potential impact these have on 
health outcomes is also recommended.  
 Given the potential for recall bias when conducting a retrospective 
investigation of ME and CFS onset patterns, future studies might employ 
prospective methods in order to track individuals’ onset patterns as they develop. 
There has been an influx of ecological momentary assessment techniques in 
health research for the purpose of tracking health symptoms and conditions over 
time (e.g., Steptoe, Gibson, Hamer, & Wardle, 2007 and Stone & Shiffman, 
1994).  These real time methods for tracking health could also be used to 
construct visual graphs that map symptoms and functioning over time, which 
could lead to interventions aimed at prevention. Furthermore, the current study 
revealed that many participants realized too late that exertion worsened their 
illness. If illness timeline graphs were developed in real-time, early intervention 
may be possible, which may also lead to better health outcomes.  Future studies 
might also investigate ways to develop efficient methods that allow patient’s to 
develop illness timelines graphs themselves. This would allow patients to 
visualize and monitor their illness trajectory as well as communicate their illness 
experience to health care providers.  Lastly, future research studies that have a 
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focus on onset assessment should utilize survey questions that more effectively 
assesses onset experiences. Specifically, an onset survey should include questions 
regarding the period of time in which first symptoms are developed, whether 
participants perceive their onset as sudden, steadily progressing, waxing and 
waning, or improving, and at what point in the patient’s illness course they realize 
the need to seek specialized medical treatment. Additionally, the survey should 
assess for early signs and symptoms, as these may be important risk factors for 
the development of the illness. A survey specifically designed to assess onset 
patterns in a large and representative sample of individuals with ME and CFS 
could provide valuable information about the prevalence of different onset 
patterns and the potential for these patterns to differentiate patients on key factors 
including etiology, illness course, and prognosis. 
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DePaul Onset Interview 
 
Opening Script:  
 
Thank you for participating in our study. During this phone interview I will be 
asking you questions about your health and illness experiences.  
 
This phone interview will take approximately 1 hour to complete. You also have 
the option of breaking up this interview into two 30-minute interviews if that is 
preferable. There may also be an additional follow up phone interview on a 
different day that will take approximately 30 minutes to complete.  
 
Please remember that you do not have to answer any questions that you do not 
feel comfortable answering and do let me know if you need to take a break or 
have any questions or concerns during the interview. Please answer the questions 
to the best of your ability. 
 
Preliminary Question:  
 
Before we begin, please tell me which illness label you use to describe your 
illness. For example, do you prefer to refer to your illness as chronic fatigue 
syndrome/CFS, myalgic encephalomyelitis/ME, or ME/CFS? Or do you use a 
different label? 
 
Main Questions 
 
1. Please tell me about the period of time when you first became sick with 
ME/CFS (use preferred illness label) 
 
*Additional follow questions to be asked as needed (i.e. if participants do 
not provide this information following the initial prompt): 
 
 Please tell me about the early days, weeks, and months of your illness 
 
Please describe to me how your illness developed during this time 
 
Please tell me more about this experience 
 
What else do you remember about that experience? 
 
What else do you remember about that period of time? 
 
Please describe how you were feeling physically 
 
Please describe how you were feeling emotionally 
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2. Please tell me about the period of time before you became sick with 
ME/CFS 
 
*Additional follow up questions to be asked as needed (i.e. if participants 
do not provide this information following the initial prompt): 
 
 Please tell me about the year before you became sick with ME/CFS 
 
If you can, please tell me about your life just before you became sick with 
ME/CFS 
 
Please tell me more about that experience 
 
What else do you remember about that experience? 
 
What else do you remember about that period of time? 
 
Please describe how you were feeling physically 
 
Please describe how you were feeling emotionally 
 
 
If not already answered ask: 
 
3.  “Over what period of time did your first symptoms develop?” 
 
 
Timeline questions 
 
Comments for interviewer: The purpose of this portion of the interview is to 
determine how participants’ functioning levels changed over the course of 
their onset, directly prior to their onset and after their onset. Participants will 
be asked to refer to the Bell CFS Disability Scale and rate their disability using 
this scale from 0-100.  
 
Participants will be asked to rate their disability level before, during, and after 
illness onset and/or first symptoms. Additionally, the interviewer should ask 
questions about significant events and symptoms occurring at time of initial 
onset, and during peaks in disability level and decreases in disability level 
(e.g. for example, if a participant experiences an additional 20 point decrease in 
disability following illness onset/initial CFS symptoms, the interviewer should 
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ask what was occurring during this timeframe and what symptoms were 
experienced).  
 
 
 
*If not already provided, ask participants to identify what year, month, time 
of year/season (if remembered), they first developed ME/CFS  
 
*Ask participant to identify whether personal experiences/events or holidays 
were coinciding with their illness development (These memorable events can 
help participants recall their onset experience). 
Year____________________________________________________________ 
 
Month___________________________________________________________ 
 
Season___________________________________________________________ 
 
Personal Events/Holidays____________________________________________ 
 
 
Functioning Questions 
 
4.  Please review the CFS Disability Scale and please tell me to the best of 
your ability what you would rate your disability level when you first became 
sick with symptoms of ME/CFS 
 
 
Please note: It is important to be flexible and follow each participant’s story and 
ask about functioning level as they describe their illness history. 
 
Additional areas to cover: 
 
Make sure to also ask about functioning level (using 0-100 scale) for the 
following areas:  
 
Just prior to illness onset/Year before illness onset: 
 
Directly following onset (i.e. how did functioning change after first 
symptoms/onset?): 
 
How did functioning change in months or years following onset? 
 
 
 
Symptoms and Significant Events  
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Please note: It is important to be flexible and follow each participant’s story and 
ask about symptoms and significant events as they describe their illness history. 
 
 
 If not already provided: What were the first symptoms that you experienced?  
When did you experience these symptoms? 
 
Also get information regarding: 
 
 Symptoms during peaks in functioning  
 
 Symptoms during decreases in functioning 
 
Make sure to gather information about:  
 
Significant events (personal, work, or health related) that occurred at 
illness onset and/or during time of first symptoms  
  
Significant events during peaks in functioning 
 
 Significant events during decreases in functioning 
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Appendix B 
Bell’s CFS Disability Scale 
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Bell- CFS Ability Scale  
100: No symptoms with exercise. Normal overall activity. Able to work or do 
house/home work full time with no difficulty. 
90: No symptoms at rest. Mild symptoms with physical activity. Normal overall 
activity level. Able to work full time without difficulty. 
80: Mild symptoms at rest. Symptoms worsened by exertion. Minimal activity 
restriction needed for activities requiring exertion only. Able to work full time 
with difficulty in jobs requiring exertion. 
70: Mild symptoms at rest. Some daily activity limitation clearly noted. Overall 
functioning close to 90% of expected except for activities requiring exertion. Able 
to work/do housework full time with difficulty. Needs to rest in day. 
60: Mild to moderate symptoms at rest. Daily activity limitation clearly noted. 
Overall functioning 70% to 90%. Unable to work full time in jobs requiring 
physical labor (including just standing), but able to work full time in light activity 
(sitting) if hours are flexible. 
50: Moderate symptoms at rest. Moderate to severe symptoms with exercise or 
activity; overall activity level reduced to 70% of expected. Unable to perform 
strenuous duties, but able to perform light duty or deskwork 4 - 5 hours a day, but 
requires rest periods. Has to rest/sleep 1-2 hours daily. 
40: Moderate symptoms at rest. Moderate to severe symptoms with exercise or 
activity. Overall activity level reduced to 50-70% of expected. Able to go out 
once or twice a week. Unable to perform strenuous duties. Able to work sitting 
down at home 3-4 hours a day, but requires rest periods. 
30: Moderate to severe symptoms at rest. Severe symptoms with any exercise. 
Overall activity level reduced to 50% of expected. Usually confined to house. 
Unable to perform any strenuous tasks. Able to perform deskwork 2-3 hours a 
day, but requires rest periods. 
20: Moderate to severe symptoms at rest. Unable to perform strenuous activity. 
Overall activity 30-50% of expected. Unable to leave house except rarely. 
Confined to bed most of day. Unable to concentrate for more than 1 hour a day. 
10: Severe symptoms at rest. Bed ridden the majority of the time. No travel 
outside of the house. Marked cognitive symptoms preventing concentration. 
0: Severe symptoms on a continuous basis. Bed ridden constantly, unable to care 
for self. 
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Appendix C 
Participant Reviewed/Corrected Illness Timeline Graphs 
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Participant 9 – 24 Hour Onset 
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Participant 3 – Onset Over 24 Hours 
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Participant 5 – Onset Over 1 Month 
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Participant 7 – Onset Over 2 to 6 Months 
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Participant 10 – Onset Over 2 to 6 Months 
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Participant 1 – Onset Over 7 to 12 Months 
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Participant 11 – Onset Over 3 or More Years 
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Participant 8 – Onset Over 3 or More Years 
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Appendix D 
Sample ME and CFS Onset Questionnaire 
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ME and CFS Onset/Illness Progression Questionnaire 
1. Please circle the response below that best describes the period of time in 
which your first symptoms of ME or CFS developed?  
a. Over 24 hours  
b. Over 1 week  
c. Over 1 month  
d. Over 2 to 6 months 
e. Over 7 to 12 months 
f. Over 1 to 2 years 
g. Over 3 or more years 
2. Over what period of time did your ME or CFS illness 
develop?_______________ 
3. Did you notice your illness progression initially? 
a. Yes 
b. No 
4. Did you experience a sudden onset of your ME or CFS illness?  
a. Yes 
b. No 
c. I do not know 
5. How would you describe your ME or CFS onset? 
______________________ 
6. Please circle the response below that best describes how your ME or CFS 
illness has progressed over time. 
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a. Steady progression (symptoms and disability accumulate in 
severity/intensity over time) 
b. Wax and Wane (symptoms and disability have a fluctuating pattern 
that includes multiple periods of improvement and decline over 
time). 
c. Other. Please 
describe:_____________________________________________ 
7. At what point during your illness progression did you experience your 
most severe decline in functioning/symptoms? 
a. At onset 
b. Within one week of onset 
c. Within one month of onset 
d. Within 2-6 months of onset 
e. Within 7-12 months of onset  
f. Within 1-2 years following onset 
g. Within 3 or more years following onset 
h. I do not know 
i. Other. Please describe:_______________________________ 
8. When during your illness progression did you realize that your illness was 
more than a typical sickness such as the flu?  
a. At onset 
b. Within one week of onset 
c. Within one month of onset 
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d. Within 2-6 months of onset 
e. Within 7-12 months of onset  
f. Within 1-2 years following onset 
g. Within 3 or more years following onset 
h. I do not know 
i. Other. Please describe:_______________________________ 
9. At what point in your ME or CFS illness progression did you realize that 
you needed specialized medical care?  
a. At onset 
b. Within one week of onset 
c. Within one month of onset 
d. Within 2-6 months of onset 
e. Within 7-12 months of onset  
f. Within 1-2 years following onset 
g. Within 3 or more years following onset 
h. I do not know 
i. Other. Please describe:_______________________________ 
 
 
 
 
